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Abstract
Autism spectrum disorders (ASD) are caused by genetic factors and a complex set of risk
factors including early stressors and alterations in the gut microbiome. The present thesis
investigated whether environmental stressors during early adolescence predisposes rats
administered another stressor in later adolescence and adulthood to produce altered anxietylike behaviours, startle response, and percent prepulse inhibition. The early adolescent
stressors used in this study included repeated administration of a bacterial endotoxin,
lipopolysaccharide (LPS), or a stressful predator cat odour exposure. In later adolescence and
adulthood, rats were administered with a gut microbial by-product, propionic acid (PPA), and
subsequently tested on behaviour. Repeated early adolescent LPS exposure induced longterm anxiety-like behaviours and elevated startle response in adulthood. Repeated early
adolescent cat odour exposure induced long-term anxiogenic effects. PPA exposure
decreased activity and percent prepulse inhibition. Combined LPS and PPA exposure
induced additive effects on activity, while prior cat odour exposure potentiated PPA’s
reduction of vertical activity. The results of this thesis are important in evaluating the
complex set of risk factors involved in the development of ASD.
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Chapter 1

1

Endotoxin and predator odour stress in adolescence and the
effects of propionic acid on subsequent behaviour

1.1

Introduction

Early life stressors can be single or multiple aversive and/or threatening events that lead
to phases of prolonged stress response activation (Pechtel & Pizzagalli, 2011). Stressors
during early life are risk factors for developing a number of clinical disorders including
anxiety and depression (Lupien et al., 2009). Acute stress responses are adaptive by
allowing the body to mobilize its resources and to utilize its coping strategies to promote
survival. However, chronic stress conditions, induced by repeated stimulation, can impair
cognitive functioning, brain development, and emotional well-being later into adulthood
(Pechtel & Pizzagalli, 2011; Lupien et al., 2009). Chronic stress during sensitive
developmental periods can also induce physiological, neurobiological, and
immunological responses (Lupien et al., 2009). Overall, given that specific brain regions
undergo growth at different time points in development, the timing of stressors can
impair specific developing brain regions (Pechtel & Pizzagalli, 2011; Andersen et al.,
2008). These stressors can also predispose individuals to enhanced sensitivity to further
environmental insults, especially during vulnerable periods such as in adolescence
(Andersen & Teicher, 2008).
Early life stressors can also predispose individuals to a variety of developmental
disorders. Developmental disorders that have been associated with early life stress and
immune activation include autism spectrum disorders (ASD). They are a group of
neurodevelopmental disorders that include the diagnosis of Autistic Disorder, Asperger
Syndrome, and Pervasive Developmental Disorder-Not Otherwise Specified (APA,
2013). There is a 4:1 male to female ratio for the prevalence of this disorder (CDC,
2012), which underlies the importance of studying males. Individuals with ASD show
deficits in social communication, restricted interests, and altered sensitivity to sensory
stimuli (APA, 2013). Although a strong genetic component can explain around 64-91%
heritability of ASD (Tick et al., 2016), its development cannot be fully explained by
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genetics. There are many cases of idiopathic regression of ASD that can occur later in
development. While some researchers point to environmental triggers, including infection
or autoimmune dysfunction (Stefanatos, 2008), more research is still necessary to
understand these cases.
Many studies using animal models of ASD examine prenatal and perinatal stressors as
risk factors for the development of this disorder (as reviewed by Gardener, Spiegelman &
Buka, 2009; Glasson et al., 2004). Most commonly, research on maternal immune
activation shows that offspring have an enhanced sensitivity to later environmental
insults to develop aberrant behaviour and regression of symptoms similar to ASD (Picci
& Scherf, 2015). Although these early developmental periods are important to study, the
adolescent period has been widely overlooked in the literature.
Adolescence is an important time-point in the developmental trajectory of humans.
During this period, adolescents face increased expectations for social and cognitive
functioning within society. These same expectations are also demanded of children with
ASD, whom must face many social and cognitive challenges as peer relationships and
social competence become increasingly important (Rosenthal et al., 2013). Unfortunately,
this period is also a time in which many psychological problems tend to emerge
(McCormick, Green & Simone, 2017). Therefore, this developmental stage is a sensitive
period to consider when assessing the impact of various stressors on subsequent
maladaptive behavioural responses.
The adolescent period in rats ranges from approximately postnatal day (P) 28 – 42, with
some changes occurring in males up to P55 (Spear, 2000). During this period, microglia,
a type of immune cell in the brain, are still relatively immature in their morphology and
may be particularly sensitive to immune insults (as reviewed by Bilbo, Smith & Schwarz,
2012). This period is also key in stress response programming and social development
(Wright, Muir & Perrot, 2012; Spear, 2000). When these developmental milestones are
impaired by stress, long-term consequences are likely to occur.
The following sections describe the effects of two types of early-life repeated stressors,
immune activation by lipopolysaccharide (LPS), and stress induced by predator odour
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(cat odour). This will be followed by a discussion on the administration of another
environmental insult, the short-chain fatty acid, propionic acid (PPA), a gut bacterial
metabolite that has been implicated in the etiology of ASD (MacFabe, 2012).

1.2

Immune activation by lipopolysaccharide (LPS)

Results of previous research suggests that individuals with ASD show elevated levels of
neuroinflammation (Pardo et al., 2005; Vargas et al., 2005; Rossignol & Frye, 2012). In a
post-mortem study of individuals with ASD, activated microglia and astroglia were
observed in the cerebellum, cortical regions, and white matter (Vargas et al., 2005). In
addition to the proinflammatory profile observed in the brain tissue, Vargas et al. (2005)
also found elevated proinflammatory cytokines in these patients’ cerebral spinal fluid.
When ASD patients were given immune system stimulation, they responded with
elevated levels of proinflammatory cytokines (TNF-α, IL-1β, IL-6) in comparison to their
controls, suggesting an abnormal innate immune response (Jyonouchi, Sun & Le, 2001).
More recently, Gupta et al. (2014) found dysregulated microglial responses with
exaggerated M2 microglial activation responsible for an anti-inflammatory response
observed in brain tissue from patients with ASD. Overall, these results may indicate an
aberrant immune response in ASD.
LPS is a bacterial endotoxin component of the cell wall of Gram-negative bacteria that
elicits inflammatory responses. LPS is also a by-product of gut bacteria, Desulfovibrio,
that is found to be elevated in individuals with ASD (Finegold et al., 2010). Peripheral
exposure to acute LPS produced chronic neuroinflammation in mice (Qin et al., 2007)
that results in long-term behavioural effects. Prenatal LPS has been shown to produce a
number of behavioural effects in adolescent rats (Foley et al., 2015). It also reduces adult
male rats’ social interaction and locomotor activity (Kirsten et al., 2010). Additionally,
prenatal LPS decreases the ability of male and female adult rats to filter out sensory
information as measured by decreased % prepulse inhibition (PPI; see Figure 1.1 for a
description of PPI) (Borrell et al., 2002). Interestingly, when treated with the
antipsychotic, haloperidol, this deficit in PPI was abolished.
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Aside from the abundant literature on prenatal LPS administration, there is limited
research on LPS administration during the sensitive period of adolescence on subsequent
behavioural measures. When acute LPS is administered in mice on P14 during the preweaning period, prolonged anxiety-like behaviours are observed when later tested in
adolescence on P30, as assessed by suppressed feeding behaviours in the center of an
open field (Dinel et al., 2014). This same acute LPS exposure on P14 also resulted in
increased depressive-like behaviours assessed in adulthood on P90 using the forced swim
task (Dinel et al., 2014). Although there is some research on repeated adolescent LPS
exposure that suggests behavioural and physiological tolerance following repeated
exposure (Wickens et al., 2017; Roth et al., 1994), there is limited research on the longterm behavioural changes induced by repeated LPS administration beyond a 72-hour
window.
Further, the immune system is tightly linked with the hypothalamic-pituitary-adrenal
(HPA) axis, such that cytokines released in response to immune stimulation activates the
HPA axis by releasing glucocorticoids from the adrenal glands (as reviewed by
Silverman et al., 2005). These glucocorticoids act as a negative feedback regulator for the
production of cytokines (Silverman et al., 2005). Peripheral administration of LPS on P14
in mice alters phosphorylation of the glucocorticoid receptors in the prefrontal cortex,
which may contribute to altered cognitive performance in adulthood and impairment of
neurogenesis (Dinel et al., 2014). As such, in addition to studying the impact of immune
insults on long-term behavioural changes, it is also imperative to study the impact of
HPA axis activation.

1.3

Predator stress (cat odour)

Aside from neuronal changes induced by a chronic state of inflammation, environmental
stressors such as predator exposure can also result in deficient neuronal development and
decreased cognitive functioning (Lupien et al., 2009). Predator odours are salient and
innate environmental stressors that have been shown to reliably elicit anxiogenic
responses and enhanced defensive behaviours (McGregor et al., 2002; Wright, Muir &
Perrot, 2013; Blanchard et al., 1998). Repeated predator odours produce a psychological
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stress response that has been used in animal models of post-traumatic stress disorder
(PTSD) (Whitaker, Gilpin & Edwards, 2014).
Predator stress can induce behavioural and endocrine changes across the lifespan. A
single acute cat odour exposure in adolescence can create anxiogenic responses on the
elevated plus maze up to 21 days following exposure (Adamec & Shallow, 1993). When
repeatedly exposed to cat odour in adolescence, rats also showed an elevated anxiety-like
response on an open field in both adolescence and adulthood (Wright, Muir & Perrot,
2013). Additionally, repeated fox feces odour exposure on P23 – P27 resulted in elevated
anxiety-like behaviour in rats as assessed by elevated plus maze in later adolescence and
decreased pain sensitivity in adulthood (Post et al., 2014). These long-term behavioural
outcomes following repeated adolescent stress indicates the importance of this sensitive
period on stress response programming.
In addition to the behavioural changes elicited by rodents in response to predator odour,
activation of the HPA axis occurs and can impact cognitive functioning and neuronal
development (Lupien et al., 2009). Cat odour exposure increases basal levels of plasma
corticosterone, indicating an activated HPA axis in rodents (Blanchard et al., 1998;
Wright, Muir & Perrot, 2013). When assessing information processing deficits that may
result from predator stress, the ability to filter out sensory information, as measured by
PPI, was decreased up to 9 days following predator stress (Bakshi et al., 2012).
Cat odour exposure may alter neural circuitry involved in PPI of an acoustic startle
response (ASR) by altering the excitatory and inhibitory balance. When rats are exposed
to cat odour, GABA levels are increased in the synapses in the hippocampus and cortex
(File, Zangrossi & Andrews, 1993). Cat odour exposure also elevates excitatory
glutamate levels that activates NMDA receptors in the amygdala to aid in the
establishment of fearful memories (Davis, Rainnie & Cassell, 1994; Ganella & Kim,
2014). This is a mechanism that has been proposed to be involved in establishing the
PTSD phenotype in rodents.
HPA axis activation by predator odour, can interact with the gut microbiome and immune
function. Corticotropin-releasing factor (CRF) can increase the gut’s permeability to
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macromolecules (Kelly et al., 2015) to be absorbed into the bloodstream. CRF can also
increase the permeability of the blood-brain barrier (BBB) (Esposito et al., 2002). Given
that HPA axis activation increases the permeability of critical barriers, it is also important
to study the interactions between environmental stressors and the gut-brain axis.

1.4

Short-chain fatty acid: propionic acid (PPA)

A subset of individuals with ASD show elevated levels of Clostridium bacteria in their
feces (Finegold et al., 2002; Song, Liu & Finegold, 2004; Parracho et al., 2005), which
produce fermentation products including PPA and other short-chain fatty acids (SCFA).
PPA has been speculated to be a likely link between the gut microbiome and ASD-like
behaviour (as reviewed by MacFabe, 2012). When administered intracerebroventricularly
(i.c.v.), PPA induces abnormal motor movements, stereotypic behaviour, restricted
interests, and impaired social interaction in adult rats (MacFabe et al., 2008; Shultz et al.,
2009) and adolescent rats (MacFabe et al., 2011). When administered peripherally in
adulthood, PPA induces aversive internal cues as measured through conditioned place
avoidance and conditioned taste avoidance (Ossenkopp et al., 2012). During the juvenile
developmental period, peripheral PPA impairs social interaction (Shams et al.,
submitted). Aside from these studies, there is currently limited research on the impact of
peripheral PPA on behaviour, and much less on adolescent behaviour.
Peripheral PPA may induce central effects by directly entering the brain via a
monocarboxylate transporter (Pierre & Pellerin, 2005) and altering cell signaling by
intracellular acidification of glia and neurons (Rörig, Klausa & Sutor, 1996). PPA, like
other SCFAs, has been shown to produce epigenetic effects by its histone deactylase
(HDAC) inhibiting activity (Bora-Tatar et al., 2009), which increases gene expression by
unraveling chromatin to allow for binding of transcription factors (Leoni et al., 2005).
HDAC inhibitors are capable of suppressing LPS-induced pro-inflammatory cytokine
production (Leoni et al., 2005). In addition, PPA has been recently shown to impair
histone decrotonylation (Fellows et al., 2018). Crotonylation is a histone posttranslational modification mechanism that alters gene expression, and occurs at high
levels in the brain (Fellows et al., 2018), which can contribute to cognitive dysfunction.
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Since PPA’s actions are tightly linked to immunity and the brain, it is conceivable that
PPA’s effects on behaviour may be impacted by prior immune or physical stress.

1.5

Objectives

The studies outlined in this thesis examined the effects of early adolescent stressors on
late adolescent and adulthood behaviour along with their interactions with other
environment insults. The objectives of the first study (Chapter 2) were to determine the
effects of early adolescent exposure of LPS on P28, P30, P32, and P34 in male LongEvans rats on anxiety-like behaviours, acoustic startle response (ASR), and prepulse
inhibition (PPI; see Figure 1.1) in later adolescence (P40 and P43) and adulthood (P74
and P77). This study also examined the effects of subsequent acute and repeated PPA in
adolescence and adulthood on behaviour. The study aimed to determine whether an
interaction effect resulted from prior repeated immune activation followed by PPA in
adolescence and adulthood.
In Chapter 3, the effects of an early adolescent repeated cat odour exposure in male
Long-Evans rats were examined on anxiety-like behaviour, ASR, and PPI in late
adolescence and adulthood. The study also examined the effects of subsequent acute and
repeated PPA in adolescence and adulthood on behaviour. The study aimed to determine
whether prior repeated stress exposure interacted with the effect of PPA to impact rodent
behaviour. Together, these studies allow us to assess the effects of early adolescent
immune stress followed by propionic acid and compare them to the effects of early
adolescent psychological stress and propionic acid on long-term behavioural outcomes.
It was hypothesized that early immune activation and predator stress would induce longterm behavioural effects on the rats by elevating anxiety-like behaviours and ASR. Acute
and repeated PPA administration was hypothesized to produce an ASD-like phenotype by
decreasing PPI. Finally, it was hypothesized that early immune activation and predator
stress would prime the rats to produce an exacerbated behavioural response to PPA.
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Figure 1.1 Acoustic startle response and % prepulse inhibition. A. Acoustic startle
response following a startle pulse. B. Normal startle response to a prepulse. C. Abnormal
startle response to a non-startling prepulse indicative of cognitive dysfunction.
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Chapter 2

2

Repeated early adolescent lipopolysaccharide exposure
followed by propionic acid treatment later in adolescence and
adulthood: effects on anxiety-like behaviours and acoustic
startle reactivity in adolescent and adult male rats

2.1

Introduction

According to the Diagnostic and Statistical Manual Fifth Edition, Autism Spectrum
Disorders (ASD) are a group of neurodevelopmental disorders that include autism,
Asperger’s syndrome, and pervasive developmental disorder not otherwise specified
(APA, 2013). ASD is characterized by deficits in social behaviours, cognitive
inflexibility, stereotyped behaviours, and hyper- or hyporeactivity to sensory input
(Carpenter, 2013). In the recent years, there has been a marked increase in the prevalence
of ASD in children from 1 out of 150 to 1 out of 68 children diagnosed with the disorder,
with approximately four males diagnosed per female (CDC, 2000; CDC, 2012), which
underlies the importance for studying males with the disorder.
Although there is no single known cause of ASD, there are several lines of research that
support genetic, neurobiological, and immunological contributions to this disorder. The
concordance rate of heritability for monozygotic twins with ASD are between 60 – 70%
(Sutcliffe et al., 2005), suggesting that environmental factors must also be involved in the
etiology of the disorder. An environmental factor that has been linked to ASD is early
infection (Sweeten et al., 2004). Prenatal immune activation has been widely used in
animal models of this disorder (Borrell et al., 2002; Kirsten et al., 2010).
Prenatal immune activation by lipopolysaccharide (LPS), a bacterial mimetic and
endotoxin found as part of the cell wall of Gram negative bacteria, has been shown to
reduce social interaction and decrease activity in adult rats (Kirsten et al., 2010). It also
disrupts prepulse inhibition (PPI) of the acoustic startle response (ASR) in adulthood
(Borrell et al., 2002). However, there is a lack of research on the impact of LPS
administration during early adolescence on adulthood.
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In humans, mental health problems tend to emerge during the developmental period of
adolescence (McCormick, Green & Simone, 2017). Peer relationships and social
competence are increasingly important during this time as adolescents navigate their
social world.
In rats, the adolescent period ranges from postnatal day (P) 28 – 42, with adolescent
changes in males that last up to P55 (Spear, 2000). During this time, immune cells in the
brain are relatively immature and may be particularly sensitive to immune insults (as
reviewed by Bilbo, Smith & Schwarz, 2012). Environmental stressors during this
sensitive period can also greatly increase the risk of psychological disorders such as
anxiety and depression (Lupien et al., 2009). Therefore, immune stress during
adolescence is likely to induce neurodevelopmental and behavioural changes in later life.
LPS can induce central effects by crossing the blood brain barrier (BBB) via a lipoprotein
transporter (Vargas-Caraveo et al., 2017), thereby activating microglia and elevating
proinflammatory cytokines, IL-1β, IL-6, IL-12, and TNF- in the brain (Qin et al., 2007).
LPS administered peripherally can also stimulate the release of pro-inflammatory
cytokines in the periphery, which can gain access to the central nervous system (CNS)
via several routes. Cytokines may pass through leaky regions at the circumventricular
organs that bypasses the BBB. Cytokine signals can also be transmitted via the vagus
nerve into the brain. Finally, cytokines can bind to carrier proteins that are expressed on
the brain endothelium, which generates prostaglandins and nitric oxide in the brain
(Raison et al., 2006; Dantzer, 2004). Proinflammatory cytokines can be produced by
macrophage cells in the brain in response to pathogens or peripheral cytokines (Dantzer,
2004). Systemic administration of LPS can result in chronic neuroinflammation and
neurodegeneration by elevating levels of proinflammatory cytokines for up to 10 months
in rodents (Qin et al., 2007). Hence, an LPS-induced increase in proinflammatory
cytokines can directly impact brain regions involved in cognition, memory, and
emotional processing, and thereby alter behaviour.
Alterations in the functions of the gut-brain axis has been implicated in the development
of ASD and other neuropsychiatric disorders. The gut microbiome is a complex array of
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commensal bacteria and other microorganisms that affect stress and neuroinflammation
(as reviewed by Rea, Dinan & Cryan, 2016). Researchers have found that the gut
microbial profile in children with ASD differs widely from those of typically developing
children. Many of these children with ASD tend to have comorbid gastrointestinal
symptoms of constipation, diarrhea, and abdominal distension (Mannion & Leader,
2014), and show elevated levels of antibiotic-resistant bacteria including Desulfovibrio,
Bacteroidetes, and Clostridium in their stool (Finegold, et al., 2010). This is concerning
since Desulfovibrio produces LPS, and Bacteroidetes and Clostridium produce a number
of metabolites including the short-chain fatty acid (SCFA), propionate (PPA), which has
been implicated in the etiology of ASD.
Acute intracerebroventricular administration of PPA in adulthood has been shown to
increase locomotor activity (MacFabe et al., 2008; Thomas et al., 2010) and induce
stereotypic movements in rats (Thomas et al., 2010). MacFabe et al., (2011) found that
these rats also show impaired social behaviour as they spend less time in the presence of
a novel rat than a novel object compared to controls. They also tended to show restricted
interests to their preferred objects. Peripheral administration of PPA can enter the CNS
from the blood via monocarboxylate transporters (Pierre & Pellerin, 2005), such that PPA
peaks in the brain after 60 minutes (Brusque et al., 1999). Behaviourally, intraperitoneal
(i.p.) administration of PPA produces aversive internal cues as measured by conditioned
place avoidance and conditioned taste avoidance (Ossenkopp et al., 2012), suggesting
that peripheral PPA may induce behavioural and cognitive changes. Repeated peripheral
PPA also impairs social interaction in juvenile rats immediately after exposure (Shams et
al., submitted). However, there is limited research on PPA administration given during
adolescence, and subsequent repeated PPA exposure on behaviour in adulthood.
The present study aimed to better understand the effects of environmental stressors on the
adolescent developmental period, as it is a sensitive period for stress response
programming and social development (Spear, 2000). The present study examined the
effect of early adolescent repeated LPS exposure on later adolescent and adulthood
behaviour. In addition, it investigated the effects of acute and repeated PPA exposure on
subsequent behaviour in adolescence and adulthood. This study examined whether prior
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LPS exposure led to an interaction with PPA on behaviour as assessed by the light-dark
anxiety task, ASR, and PPI. It was hypothesized that LPS would induce anxiety-like
behaviour that persists into late adolescence and adulthood. It was further hypothesized
that PPA would produce altered cognitive functioning as assessed by PPI. These effects
of PPA were hypothesized to be augmented by prior exposure to immune activation by
LPS.

2.2
2.2.1

Materials and Methods
Subjects

Fifty-six male Long Evans rats (Charles River, Quebec, Canada) were obtained at 51 - 75
g, which corresponds to the age of postnatal day (P) 22. All animals were pair-housed
with another rat of the same treatment group in standard polypropylene cages (45 x 22 x
20 cm) and maintained in a temperature-controlled room at 20 ± 1°C on a 12:12 lightdark cycle (lights on at 0700 to 1900 h). All animals had ad libitum access to food (RHM
Prolab 3000 rat chow) and tap water. Rats were identified using a numeric system and
marked with permanent marker on their tails. When markings faded, the rats were remarked. All experimental procedures complied with the Canadian Council for Animal
Care and the Institutional Animal Care Committee.

2.2.2

Drugs

Lipopolysaccharide (LPS; from E. coli serotype 0111:B4, L-2630, Sigma-Aldrich, St.
Louis, MO, USA) at a dose of 0.2 mg/kg was dissolved in 0.9% NaCl and injected in
early adolescence on P28, P30, P32, and P34. A vehicle control using 0.9% NaCl was
injected on these same days. All treatments were administered intraperitoneally (i.p.) at
2.0 ml/kg body weight. A no treatment control (No Tx) group was lightly handled on
these days. The dose of 0.2 mg/kg of LPS was chosen as it produces a significant dosedependent reduction of ASR (Lockey, Kavaliers & Ossenkopp, 2009). To ensure that the
behaviours detected by the behavioural assays were not just products of the sickness
behaviours induced by LPS within a 24 hour post-injection period (Custódio, et al., 2013;
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Dantzer et al., 2008), animals were behaviourally tested at least six days after the last
LPS injection.
Sodium propionate (P1880, Sigma-Aldrich, St. Louis, MO, USA) at a dose of 500 mg/kg
was dissolved in 0.1 M phosphate buffered saline (PBS) and buffered to pH of 7.5 by
HCl. This dose was chosen as it produces reduced locomotion on the conditioned place
avoidance task (Ossenkopp, et al., 2012). Sodium propionate and PBS were administered
in late adolescence on P40 and P43, and in adulthood on P74 and P77.

2.2.3

% Body Weight Change

Body weight decrease (O’Connor et al., 2009) was used as an indicator of an LPSinduced sickness response. It was calculated using the following formula:
% 𝐵𝑜𝑑𝑦 𝑊𝑒𝑖𝑔ℎ𝑡 𝐶ℎ𝑎𝑛𝑔𝑒
= 100 ×

2.2.4

24ℎ 𝑝𝑜𝑠𝑡 𝑡𝑒𝑠𝑡 𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 − 𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡

Light-Dark Apparatus & Behavioural Measures

Anxiety-like behavioural variables from the light-dark apparatus were collected using
eight VersaMax Animal Activity Monitors (Accuscan Model RXYZCM-16, Columbus,
OH). Monitors were made of clear Plexiglas (42 x 42 x 30 cm) enclosed by a Plexiglas
lid containing air-holes. The box was equipped with 16 infrared sensors located every
2.54 cm along the perimeter and 7 cm above the floor. Another 16 sensors were located
18 cm above the floor on opposite sides. This apparatus was divided into a light or dark
chamber using a black opaque Plexiglas box insert (40 x 20 x 23 cm). The light chamber
was illuminated by 3 fluorescent light sources located above the monitors. The dark
chamber has small holes located on the sides to permit infrared beams to pass through. A
hole in the partition between the light and dark chambers at floor level allowed for the rat
to freely pass between chambers. Data were collected and analyzed by a VersaMax
Analyzer (Accuscan Model CDA-8, Columbus, OH) and sent to a computer where it was
recorded and retrieved. Procedures were adapted from Banasikowski et al. (2015).
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The VersaMax Analyzer collected two types of behavioural variables: chamber-choice
and activity variables (Table 2.1). The chamber-choice variables included the duration of
time spent in the light chamber and the number of transitions to the light chamber. These
variables provide measures for risk assessment and anxiety-like behaviours demonstrated
by avoidance of the light chamber (Ossenkopp et al., 2005; Banasikowski et al., 2015).
The other type of behavioural variables collected by the VersaMax Analyzer were
activity variables in both the light and dark chambers. These included the total
cumulative distance travelled and time spent in a vertical position. All activity variables
were corrected for the total time spent in their respective chambers. For example, the
corrected total distance travelled in the light chamber was calculated as the total distance
travelled per second spent in the light chamber.
Table 2.1 Behavioural measures recorded on the light-dark anxiety task
Behavioural Measures
Chamber Choice Variables
Light Duration
Chamber Transitions
Activity Variables
Total Distance
Vertical Time

2.2.5

Definition
Time spent in the light chamber.
Number of transitions between the light and dark
chambers.
Cumulative horizontal distance travelled.
Time spent in rearing position. This measure does not
consider the time when animal goes below the vertical
sensor.

Acoustic Startle Response & Prepulse Inhibition

Acoustic startle response (ASR) and pre-pulse inhibition (PPI) testing were conducted in
three startle devices (SRLAB, San Diego Instruments, San Diego, CA). Each apparatus
consisted of a cylindrical, clear acrylic rat enclosure (8.89 cm inside diameter and 20.32
cm length) mounted on an acrylic platform. A piezoelectric accelerometer that lies
underneath the platform detected the force of the rat’s non-voluntary movement. This
apparatus was placed inside a ventilated sound attenuated box containing fluorescent
lighting and a speaker which was 11 cm from the top back of the box. Data were recorded

21

and stored by a computer attached to the accelerometer. Procedures were adapted from
Lockey, Kavaliers, and Ossenkopp (2009).
The startle responses were measured as the magnitude of the maximum voltage detected
by the startle device. The average peak voltage response for Startle, 76 dB PPI and 82 dB
PPI trials were computed. Percent PPI was calculated as a percent difference from the
startle-only startle response for the 76 dB and 82 dB pre-pulse level. This was calculated
using the following formula:
% 𝑃𝑃𝐼 = 100 ×

𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑜𝑛𝑙𝑦 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒 − 𝑃𝑃𝐼 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒
𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑜𝑛𝑙𝑦 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒

Habituation to the startle stimulus was measured using percent habituation to the startle
stimuli. This was calculated using the following formula:
% 𝐻𝑎𝑏𝑖𝑡𝑢𝑎𝑡𝑖𝑜𝑛
= 100 ×

2.2.6

𝑎𝑣𝑔 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑜𝑛 𝑡𝑟𝑖𝑎𝑙𝑠 6 𝑡𝑜 10 − 𝑎𝑣𝑔 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑜𝑛 𝑙𝑎𝑠𝑡 5 𝑡𝑟𝑖𝑎𝑙𝑠
𝑎𝑣𝑔 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑜𝑛 𝑡𝑟𝑖𝑎𝑙𝑠 6 𝑡𝑜 10

Experimental Procedure

Rats were assigned to five weight-matched manipulation groups: 1. LPS-PPA, 2. LPSPBS, 3. NaCl-PPA, 4. NaCl-PBS, and 5. No Tx. On the day of arrival, rats were pairhoused without manipulation for three days to habituate them to the facility. They were
handled on their fourth and fifth day, and weighed on their sixth day (see Error!
Reference source not found.).

2.2.6.1

Phase 1: Adolescence

According to Spear (2000), the adolescent period in rats occurs from approximately P28 P42. In males, the adolescent phase has been suggested to last until P55. Repeated
administration of the bacterial endotoxin, LPS, its vehicle, or No Tx, occurred in early
adolescence on P28, P30, P32, and P34. Rats were weighed every day at approximately
the same time per day throughout the LPS treatments.
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Figure 2.1 Experimental timeline.
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The rats were given six days to recover from the LPS insult before they were injected
with PPA, its vehicle, or received No Tx on P40. After waiting 15 minutes for PPA to
take effect, rats were tested in the light-dark apparatus for 15 minutes. Between each
testing session, the apparatus was cleaned with detergent and water, followed by baking
soda in water to remove odours, and dried with paper towel to remove remaining stains.
On P43, the rats were again weighed and injected with PPA, PBS, or received No Tx.
After waiting 10 minutes, the rats were placed in the startle apparatus. Each testing
session began with a 5 min acclimation period with continuous background noise at 70
dB. The 11 min testing phase consisted of 45 trials starting with 10 startle-only trials at
120 dB presented for 40 ms. The subsequent 30 trials were presented in pseudorandomized order: 10 startle-only (120 dB for 40 ms) and 20 PPI trials (ten 76 dB and ten
82 dB non-startling pulses presented for 20 ms and a 120 ms wait until the 120 dB startle
pulse). The session ended with 5 startle-only trials (120 dB for 40 ms). The startle
response was recorded by a computer for 100 ms following the onset of the startle
stimulus. All trials were separated by an inter-trial interval (ITI) of 8-23 seconds in length
(average ITI = 15 seconds). The apparatus was calibrated every four testing sessions to
ensure consistency in recording. Between each testing session, the animal enclosure was
cleaned with detergent and water, and dried with paper towel to remove remaining stains.

2.2.6.2

Phase 2: Adulthood

The same procedure used in late adolescence on P40 and P43 were conducted in
adulthood on P74 and P77, respectively, with injections of PPA, PBS, or No Tx on those
days followed by either light-dark testing or startle testing.

2.2.7

Statistical Analyses

All statistical analyses were completed using IBM SPSS Statistics 24. On the percent
body weight change measure, repeated measures analyses of variances (ANOVA) was
conducted comparing the interaction effect between postnatal day and LPS treatment.
Greenhouse-Geisser corrections were used for repeated measures analyses that violates
Mauchly’s Test for Sphericity.
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Repeated measures ANOVA for the behavioural measures from the light-dark and startle
tasks compared the treatment effects between adolescence and adulthood. The betweensubject factors were the treatment groups and the within-subject factors were the
adolescent and adulthood time-points. LSD post-hoc pairwise comparisons were
performed with a significance criteria set to α = 0.05 for all hypotheses tested.

2.3

Results

2.3.1

% Body Weight Change

There was a postnatal day by LPS treatment interaction effect on % body weight change
24-hours after LPS injection F(3.106, 82.317) = 8.433, p < .001 (Figure 2.2). The body
weight decrease observed on P28 in the LPS administered rats was significantly different
from both the NaCl and No Tx group (ps < .001). On P30, the LPS administered rats
showed a lower body weight increase in comparison to both control groups (NaCl: p =
.001, No Tx: p = .043). No significant differences were observed on P32.

2.3.2
2.3.2.1

Light-Dark: Anxiety & Activity
Chamber-Choice Variables

There were no significant age by treatment effects on the duration spent in the light
chamber (Figure 2.3) However, there was a main effect of PPA when combining the rats
in adolescence and adulthood, whereby PPA-treated rats spent less time in the light
chamber than their PBS controls (p = .040; Figure 2.3).
There were no significant age by treatment effects on the number of transitions into the
light chamber (Figure 2.4). There was a main effect of LPS when combining the rats in
adolescence and adulthood, such that LPS-treated rats showed fewer transitions into the
light chamber compared to their NaCl controls (p = .020). There was a main effect of
PPA, whereby PPA-treated rats showed fewer number of transitions into the light
chamber compared to their PBS controls when adolescence and adulthood were
combined (p < .001) (Figure 2.4).
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Figure 2.2 Percent body weight change 24-hours post-injection. Rats were injected
i.p. with LPS (n = 24), NaCl (n = 24), or had No Tx (n = 8) on P28, 30, 32, and 34
depending on their treatment condition. The LPS-treated rats showed a decrease in body
weight in comparison to the control groups 24 hours following the first and second
injections. This effect was absent on P32. *p < .05, **p < .01, ***p < .001. Data is
represented as means ± SEM.
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Figure 2.3 Duration spent in the light chamber of the light-dark apparatus on P40
and P74. Rats were injected i.p. with LPS, NaCl, or had No Tx on P28, 30, 32, and 34
and PPA, PBS, or had No Tx on P40, 43, and 74 (n = 12/injected group, n = 8/No Tx
group). There were no significant age by treatment effects. There was a main effect of
PPA treatment as seen in the graph on the right, such that PPA-treated rats showed
decreased duration into the light chamber compared to their PBS controls. *p < .05. Data
is represented as means ± SEM.
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Figure 2.4 Number of transitions into the light chamber of the light-dark apparatus
on P40 and P74. Rats were injected i.p. with LPS, NaCl, or had No Tx on P28, 30, 32,
and 34 and PPA, PBS, or had No Tx on P40, 43, and 74 (n = 12/injected group, n = 8/No
Tx group). There were no significant age by treatment effects. There was a main effect of
LPS treatment as seen in the graph on the top right, whereby LPS-treated rats showed
decreased transitions into the light chamber compared to their NaCl controls. There was a
main effect of PPA treatment as seen in the graph on the bottom right, such that PPAtreated rats showed decreased transitions into the light chamber compared to their PBS
controls. *p < .05, ***p < .001. Data is represented as means ± SEM.
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2.3.2.2

Activity Variables: Corrected Horizontal Locomotion

In the light chamber, there were no significant age by treatment effects on the corrected
horizontal locomotor measures in the light chamber.
In the dark chamber, corrected total distance travelled showed an age by treatment
interaction effect, F(4, 51) = 3.944, p = .007, whereby in adolescence, the LPS-PPA
group showed a lower corrected dark total distance travelled in comparison to the LPSPBS, NaCl-PBS, and No Tx control groups (ps < .05; Figure 2.5). The LPS-PBS group
showed a lower corrected dark total distance travelled in comparison to the NaCl-PBS
and No Tx groups (ps < .05). Finally, the NaCl-PPA group showed a significantly lower
corrected dark total distance travelled in comparison to the NaCl-PBS and No Tx control
group (ps < .05). In adulthood, the LPS-PPA group maintained a lower corrected dark
total distance than the LPS-PBS and NaCl-PBS group (ps < .05). When analyzing the
main effects of LPS when combining adolescence and adulthood, the LPS-treated rats
showed decreased corrected dark total distance than their NaCl and No Tx controls (ps <
.05). There was also a main effect of PPA, whereby PPA-treated rats showed decreased
corrected dark total distance compared to their PBS and No Tx controls (ps < .05).

2.3.2.3

Activity Variables: Corrected Vertical Locomotion

On corrected vertical time in the light chamber, there was a trending age by treatment
effect, F(4, 51) = 2.552, p = .050. There was an age by LPS effect, F(1, 51) = 7.263, p =
.010 (Figure 2.6B), such that LPS-treated rats showed an increased corrected light
vertical time in adulthood compared to adolescence (p < .001). Further, the No Tx group
showed a similar increase in corrected light vertical time in adulthood (p = .001).
However, this was not seen in the NaCl control group. There was a main effect of PPA
when adolescence and adulthood were combined, whereby PPA-treated rats exhibited
less vertical movement time in the light chamber than their PBS controls (Figure 2.6A).
In the dark chamber, fewer treatment effects were found. There was a main effect of PPA
treatment, such that PPA-treated rats showed decreased vertical movement time
compared to their PBS controls (p = .009; Figure 2.7).
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Figure 2.5 Corrected total distance travelled in the dark chamber of the light-dark
apparatus on P40 and P74. Rats were injected i.p. with LPS, NaCl, or had No Tx on
P28, P30, P32, and P34 and PPA, PBS, or had No Tx on P40, P43, and P74 (n =
12/injected group or n = 8/No Tx group). Corrections were made by dividing by the
duration spent in the dark chamber. In both adolescence and adulthood, the LPS-PPA rats
travelled less distance than their NaCl-PBS controls. There was a main effect of LPS as
seen in the graph on the top right, such that LPS-treated rats also showed decreased total
distance travelled in the dark chamber than the NaCl and No Tx controls when
adolescence and adulthood were combined. There was a main effect of PPA as seen in
the graph on the bottom right, whereby PPA-treated rats showed decreased total distance
travelled in the dark chamber than PBS and No Tx controls when adolescence and
adulthood were combined. *p < .05, **p < .01, ***p < .001. Data is represented as means
± SEM.
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A)

B)

Figure 2.6 Corrected vertical time in the light chamber of the light-dark apparatus
on P40 and P74. Rats were injected i.p. with LPS, NaCl, or had No Tx on P28, P30, P32,
and P34 and PPA, PBS, or had No Tx on P40, P43, and P74 (n = 12/injected group or n =
8/No Tx group). Corrections were made by dividing by the duration spent in the light
chamber. A) There was a main effect of PPA as seen in the graph on the right, such that
PPA-treated rats spent less time in vertical position than PBS and No Tx controls. B) In
adolescence, the LPS-treated rats spent less time in vertical position than in adulthood.
The No Tx controls showed the same increase in vertical time in adulthood compared to
adolescence. *p < .05, **p < .01, ***p < .001. Data is represented as means ± SEM.
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Figure 2.7 Corrected vertical time in the dark chamber of the light-dark apparatus
on P40 and P74. Rats were injected i.p. with LPS, NaCl, or had No Tx on P28, P30, P32,
and P34 and PPA, PBS, or had No Tx on P40, P43, and P74 (n = 12/injected group or n =
8/No Tx group). Corrections were made by dividing by the duration spent in the dark
chamber. There was a main effect of PPA as seen in the graph on the right, such that
PPA-treated rats spent less time in vertical position in the dark chamber than their PBS
controls. **p < .01. Data is represented as means ± SEM.
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2.3.3

Acoustic Startle Response (ASR) & Percent Prepulse
Inhibition (%PPI)

The average ASR also showed an age by LPS interaction effect, such that the LPS-treated
rats showed an increased ASR in adulthood compared to adolescence, F(1, 51) = 8.030, p
= .007 (Figure 2.8B), such that LPS increased average ASR to levels greater than their
controls in adulthood (p = .018).
On average ASR, there was an age by treatment group effect, F(4, 51) = 3.362, p = .016
(Figure 2.8A). In adolescence, the LPS-PPA group showed a lower ASR than the LPSPBS (p = .044) and No Tx control group (p = .014). The NaCl-PPA group showed a
lower ASR than the No Tx group (p = .025). In adulthood, the LPS-PBS group showed a
steep increase in startle response in comparison to adolescence (p < .001), where the
response was greater than that presented by all other treatment groups, except the No Tx
control group. The average ASR also showed an age by LPS interaction effect, such that
the LPS-treated rats showed an increased ASR in adulthood compared to adolescence,
F(1, 51) = 8.030, p = .007 (Figure 2.8B), such that LPS increased average ASR to levels
greater than their controls in adulthood (p = .018). There was a main effect of LPS when
both adolescence and adulthood were combined (Figure 2.8A), observed by LPS-treated
rats showing greater ASR than the NaCl controls (p = .048). There was also a main effect
of PPA combining both adolescence and adulthood, whereby PPA-treated rats showed a
decreased ASR in comparison to their PBS controls (p = .043).
When given a 76 dB pre-pulse, 6 dB above background noise, an age by treatment
interaction effect was observed, F(4, 51) = 2.649, p = .044 (Figure 2.9A), such that in
adolescence, the NaCl-PPA group had a lower %PPI than the NaCl-PBS controls (p =
.046). In addition, the 76 dB %PPI of LPS-PPA (p = .001), NaCl-PPA (p < .001), and the
No Tx controls (p = .001) was lower in adolescence than in adulthood, such that in
adulthood, their %PPI levels were normalized across all treatment groups. There was also
an age by PPA interaction effect, F(1, 51) = 7.253, p = .010, whereby PPA decreased the
76 dB %PPI in adolescence compared to their controls (p = .023; Figure 2.9B). This
decreased %PPI observed in PPA rats normalized in adulthood, at which point their %PPI
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became similar to all other treatment groups. When given an 82 dB pre-pulse, 12 dB
above background noise, an age by treatment interaction effect was observed, F(4, 51) =
2.688, p = .041 (see Appendix A.1), such that in adolescence, the LPS-PPA group
showed a decreased %PPI in comparison to the NaCl-PBS group (p = .038).
On % habituation, there was an age by treatment interaction effect, F(4, 51) = 2.873, p =
.032 (Figure 2.10). In adulthood, the No Tx group showed greater % habituation to the
startle response than the injection groups (ps < .05), except LPS-PBS. The No Tx group
showed an increase in % habituation to the startle response across age (p = .002).

2.3.4

Summary of Results

This study showed that early adolescent repeated LPS exposure reduced activity long
after LPS administration when tested in later adolescence and adulthood. Rats exposed to
LPS produced less transitions into the light chamber, which in conjunction with the
former results indicates elevated anxiety levels in these rats. Additionally, early
adolescent repeated LPS exposure produced a delay in increase in ASR that occurred in
adulthood. PPA decreased activity on both horizontal and vertical measures, and
decreased duration in the light chamber, which taken together indicates an aversive
internal state which presented itself as elevated levels of anxiety and a decreased
motivation to move. In adolescence, PPA administration produced decreased %PPI as a
measure of sensorimotor gating. PPA showed no effect on %PPI in adulthood compared
to their controls. Further, PPA decreased overall startle response when adolescence and
adulthood were combined. On the activity behavioural measures, the effects of LPS and
PPA occur in an additive fashion. However, the effects of LPS and PPA oppose each
other on ASR, the measure of sensory sensitivity, whereby LPS increases ASR in a
delayed fashion, while PPA depresses ASR.
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A)

B)

Figure 2.8 Average acoustic startle response for a 120 dB pulse on P43 and P77. Rats
were injected i.p. with LPS, NaCl, or had No Tx on P28, 30, 32, and 34 and PPA, PBS, or
had No Tx on P40, 43, 74, and 77 (n = 12/injected group or n = 8/No Tx group). A) In
adolescence, the LPS-PPA group had a lower ASR than the No Tx group. In adulthood,
the LPS-treated rats had a greater ASR in comparison to their controls. There was a main
effect of LPS as seen in the graph on the top right, such that LPS-treated rats exhibited a
greater ASR than their NaCl controls. There was a main effect of PPA as seen in the
graph on the bottom right, such that PPA-treated rats exhibited a lower ASR than their
PBS controls. B) LPS treatment elevated average ASR in adulthood compared to
adolescence. In adulthood, the LPS-treated rats showed a greater ASR than their NaCl
controls. *p < .05, **p < .01, ***p < .001. Data is represented as means ± SEM.
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A)

B)

Figure 2.9 % Prepulse Inhibition for a 76 dB prepulse on P43 and P77. Rats were
injected i.p. with LPS, NaCl, or had No Tx on P28, 30, 32, and 34 and PPA, PBS, or had
No Tx on P40, 43, 74, and 77 (n = 12/injected group or n = 8/No Tx group). A) In
adolescence, the NaCl-PPA group showed a decreased %PPI than the NaCl-PBS group
for a 76 dB prepulse. The LPS-PPA, NaCl-PPA, and No Tx groups experienced an age
increase in %PPI. B) PPA-treated rats showed a decreased %PPI for a 76 dB in
adolescence compared to adulthood. In adolescence, the PPA group showed a lower
%PPI for a 76 dB prepulse compared to PBS controls. In adulthood, there were no
significant differences between treatment groups. *p < .05, **p < .01, ***p < .001. Data
is represented as means ± SEM.
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Figure 2.10 % Habituation of the startle response from the first 6 to 10 trials to the
last 5 trials on P43 and P77. Rats were injected i.p. with LPS, NaCl, or had No Tx on
P28, 30, 32, and 34 and PPA, PBS, or had No Tx on P40, 43, 74, and 77 (n = 12/injected
group or n = 8/No Tx group). In adulthood, the No Tx group showed greater %
habituation to the startle response than the injection groups, except LPS-PBS. The No Tx
group showed an increase in % habituation to the startle response across age. *p < .05,
**p < .01. Data is represented as mean ± SEM.
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2.4
2.4.1

Discussion
Early adolescent repeated LPS exposure increased
anxiety-like behaviour, escape behaviour, and produced
long-term effects on startle response

In many species, the early adolescent period is a vulnerable period, where there are
prominent changes in the prefrontal cortex and limbic regions (Spear, 2000). Exposure to
immune challenges during this period are critical to development and were explored in
the present study. When rats were administered LPS repeatedly in early adolescence,
long-term behavioural changes were induced when tested later in adolescence and in
adulthood. LPS induced anxiety-like behaviours in adolescence and adulthood as
demonstrated by a decreased number of transitions into the light chamber and decreased
horizontal locomotion in the dark chamber when adolescence and adulthood were
combined. In the light-dark task, it was advantageous to present normal locomotor
activity in the risky brightly lit environment to avoid potential predators. However, in the
dark chamber that was considered safe, the rats resumed their abnormal behaviours.
Hence, fewer treatment differences were observed on activity measures in the light
chamber compared to the dark chamber.
The results of this study taken together indicate that the LPS-treated rats display
aversiveness to the brightly lit chamber. This is consistent with previous research on
neonatal LPS-treated rats, such that LPS treatment resulted in more time spent hiding in a
hide box on an open field in adulthood (Walker et al., 2009). In the present study, prior
LPS treatment induces decreased activity in the dark chamber after injection stress,
consistent with double-hit models of psychopathology. When LPS is administered
neonatally followed by stress exposure in adulthood, a decreased general activity in male
rats is observed to a greater extent than the rats only exposed to neonatal LPS without the
stress exposure (Walker et al., 2009). The present study used early adolescent repeated
LPS exposure followed by PPA and stressful behavioural testing resembling multiple
stress hits, which are predictive of behavioural dysfunction and psychopathology
(Maynard et al., 2001; Picci & Scherf, 2015).
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In adolescence, the rats administered repeated LPS six days prior spent less time in
vertical position in the light chamber compared with adulthood. In adulthood, these
vertical locomotor levels of the LPS-treated rats returned to levels comparable to their
controls. This provides an approximate timeline by which depressive-like symptoms
dissipate following repeated early adolescence LPS administration. The decrease in
vertical locomotion observed in adolescence was not surprising as previous research on
neonatal LPS treatment also induced decreased exploration on the open arms of the
elevated plus maze in adulthood (Walker et al., 2004). This decreased exploration and
escape behaviour observed in rats administered LPS resemble depressive-like behaviours,
as these rats show less motivation to escape the aversive stimuli.
Early adolescent repeated LPS-treated rats produced an increased ASR in adulthood in
comparison to adolescence. This delay in increased ASR is consistent with prior research
where neonatal exposure to LPS predisposed animals to an elevated ASR when given
restraint stress in adulthood (Walker et al., 2008). This elevated ASR may be driven by
increased HPA axis activity in response to stressors as indicated by elevated
corticosterone following LPS exposure (Shanks et al., 2000; Nilsson et al., 2002; Walker
et al., 2008). Further, early LPS induces a long-term proinflammatory state into
adulthood by elevating proinflammatory cytokines: IL-2, IL-6 (Borrell et al., 2002) and
TNF- (Qin et al., 2007; Tedelind et al., 2007), which can explain why the effects of LPS
are sustained 45 days after the rats’ last exposure.
During the LPS treatment days, it was imperative to ensure that LPS induced an immune
challenge to the rat. As such, the body weight decrease observed 24 hours after the first
two LPS injections were indicative of an immediate sickness response. By the third
injection, a tolerance effect was observed, such that body weight change became no
different from the controls, as expected from prior research (Chan et al., 2013; CrossMellor et al., 2009). Since repeated constant doses of LPS exposure induces a tolerance
effect, future studies using repeated LPS to induce a chronic inflammatory state may
choose to use increasing doses of LPS. According to Wickens et al. (2017), increasing
repeated doses of LPS produced a more sustained behavioural response on the forced
swim test, measured by increased immobility time than produced by a constant dose of
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LPS. Perhaps, the repeated immune activation in adolescence produced by increasing
LPS doses may result in greater behavioural changes.

2.4.2

PPA administration increased anxiety-like behaviour,
decreased activity, and decreased sensorimotor gating

Intracerebroventricular (i.c.v.) administration of PPA has been shown to elicit bouts of
abnormal behaviours including hyperextension of the body to the surface, rotation, and
contraction of limb muscles (MacFabe et al., 2007). These behaviours observed using a
central route of administration are also observed anecdotally through the peripheral route
of administration used in the present study. This transient behaviour returned to normal
over a couple of minutes, after which behavioural testing occurred. In the present study,
PPA increased anxiety-like behaviours in rodents and decreased activity localized in the
dark chamber of the light-dark apparatus. Similar to the effect of LPS, PPA-treated rats
showed greater aversiveness to the brightly lit chamber than their PBS controls. The
PPA-administered rats showed decreased horizontal locomotor levels in the dark
chamber of the light-dark apparatus as well as decreased vertical locomotor variables in
both the light and dark chambers when adolescence and adulthood were combined,
indicating a decreased motivation to move. The decrease in vertical locomotion was not
surprising as this result confirms prior findings that PPA produces an unconditioned
reduction of vertical movement numbers on the first trial of a conditioned place aversion
task (Ossenkopp et al., 2012). This evidence for decreased activity using the peripheral
route of PPA administration is contrary to the hyperlocomotion observed using i.c.v.
administration. It was also interesting that PPA altered behaviours even in the brightly lit
chamber where the rats should be presenting as normal locomotor activity as possible.
These observable behavioural abnormalities indicate an aversive internal state as
described by Ossenkopp et al. (2012) which presented itself as a decreased interest in
exploration and altered ability to avoid predators.
In addition to the decreased activity and exploration, PPA administration also decreased
that rats’ sensorimotor gating ability. They showed a decreased ability to modulate the
startle response when given a prepulse, which is indicative of a maladapted ability to
filter out redundant auditory stimuli. The proposed neural circuit involved in PPI is
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composed of the auditory system (cochlear nuclei, superior olivary complex and nuclei of
the lateral lemniscus), the inferior and superior colliculus, and pedunculopontine
tegmentum, which conveys information to the pontine reticular nucleus (Koch, 1999).
This is all modulated by input from the prefrontal cortex, hippocampus, amygdala,
ventral tegmental area, and nucleus accumbens (Koch, 1999). PPI is not only affected by
sensorimotor integration, but also requires attentional systems that allow for perception of
the prepulse stimulus (Dawson et al., 1993). Therefore, altered PPI as evidenced by PPA
administration is a result of cognitive dysfunctioning.
Some putative modes of action for peripheral PPA administration are as follows. PPA is a
known ligand for the short-chain fatty acid G-protein coupled receptors: FFAR2 and
FFAR3. FFAR2 is expressed on a number of immune cells including leukocytes (Nøhr et
al., 2013), monocytes, and neutrophils (Ang, Er & Ding, 2015). Peripheral PPA may also
take central effects by passing the blood-brain barrier via the monocarboxylate
transporter (Pierre & Pellerin, 2005). Peripheral PPA has been shown to enter the brain
and peak at 60 minutes following administration (Brusque et al., 1999). Given that PPA
has been observed to activate microglia of the hippocampus, white matter, cingulate, and
neocortex (MacFabe et al., 2011), it is surprising that FFAR2 are not expressed on
microglia, which are the resident immune cells of the central nervous system (Sampson et
al., 2016; Erny et al., 2015). However, once PPA enters the brain, it can alter the
excitatory and inhibitory balance in neural circuitry via increased glutamatergic and
decreased GABAergic transmission (MacFabe, 2012). PPA can also induce intracellular
acidification of neurons and glia, leading to disrupted synaptic transmission in the
prefrontal cortex and sensorimotor cortex (Rörig et al., 1996), which are key brain
regions involved in sensorimotor gating.
The PPA administration regimen occurred on two days in adolescence, and two days in
adulthood. Their cumulative action may have produced central effects through epigenetic
action. This may explain why PPA’s effects on sensorimotor gating were so prominent in
adolescence following PPA’s second injection. SCFAs including propionate act
epigenetically via its histone deacetylase (HDAC) inhibiting activity and impairment of
histone decrotonylation (Fellows et al., 2018). Crotonylation is a histone post-
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translational modification mechanism that alters gene expression. It was found that high
levels of histone crotonylation occur in the brain (Fellows et al., 2018). Therefore, it is
likely that propionate, an HDAC inhibitor, may alter cognitive functioning through this
manner. However, further research is warranted as the present study found that PPA
administration in adulthood showed little behavioural effects.
Although research on repeated PPA administration is scarce, there is some research on a
double-hit model of PPA exposure that occurs prenatally and postnatally. This model
induced elevated behavioural changes in adolescence measured through increased ASR
(Foley et al., 2015). Although this study suggests that a double-hit of PPA induces altered
sensory sensitivity, the present study did not show these same results. The results of the
present study did not show an increased ASR in adulthood compared to adolescence
when PPA was administered in both time points. These findings may be a result of
methodological differences particularly in the timing of PPA administration. Perhaps
prenatal administration may result in exacerbated behavioural changes in adulthood that
cannot be achieved by adolescent exposure. Further, the diminished behavioural changes
observed in adulthood PPA administration perhaps indicates a behavioural tolerance to
the drug. Further research is necessary to better understand the behavioural tolerance
produced by PPA following repeated exposures in adolescence and adulthood.

2.4.3

Prior repeated LPS exposure and PPA together decreased
activity in additive fashion, but also produced opposing
effects on startle response

Prior repeated exposure to the immune agent, LPS, followed by acute exposure to PPA
decreases activity in an additive fashion. Although no interaction effects were found in
behaviour, there may be physiological interactions which cannot be assayed by this study.
For instance, LPS i.p. has been found to increase intestinal permeability by increasing
enterocyte membrane toll-like receptor 4 expression (Guo et al., 2013). The gut barrier
plays an important role of preventing the systemic circulation of bacterial antigens from
the gut. Hence, gut permeability could lead to faster absorption of endogenous PPA.
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Interestingly, LPS and PPA produced opposing effects on ASR, where LPS increased the
magnitude of the ASR, while PPA decreased the magnitude of the ASR compared to their
vehicle controls. This is consistent with a prior study conducted by Foley et al. (2015),
where prenatal LPS-induced increases in ASR that were attenuated in postnatal PPA
treated rats. This effect may result from PPA’s anti-inflammatory properties, as it has
previously been shown to reduce proinflammatory cytokines (Tedelind et al., 2007).
Early LPS exposure induces a proinflammatory state into adulthood demonstrated by
elevated levels of IL-2, IL-6 (Borrell et al., 2002) and TNF- (Qin et al., 2007; Tedelind
et al., 2007). PPA can suppress this LPS-induced TNF- release from neutrophils
(Vinolo et al., 2011; Tedelind et al., 2007) and can decrease IL-6 mRNA levels (Tedelind
et al., 2007). Aside from PPA’s anti-inflammatory properties which counteracts the
effects of LPS, PPA can also act as a histone deacetylase (HDAC) inhibitor (Nguyen et
al., 2007). By increasing histone H4 acetylation, histone deacetylase inhibitors are
capable of suppressing microglial over-activation produced by LPS (Chen et al., 2007).
PPA interacts with the immune system as it is a ligand for FFAR2 (Brown et al., 2003), a
G-protein coupled receptor found on immune cells. When administered LPS, FFAR2
expression in monocytes increased (Senga et al., 2003), suggesting that FFAR2 is
involved in innate immunity. This provides another link between LPS and PPA activity.
FFAR2 activation has been associated with anti-inflammatory effects, such that
propionate treatment decreased the production of LPS-induced elevation of
proinflammatory cytokine, IL-6, to levels comparable to controls not administered LPS
(Li et al., 2018). In the same study, propionate also decreased the TNF-α induced
elevation of IL-6. Although no behavioural interaction effects were found in the present
study, it is important to consider the possible physiological and immunological
interactions that may have occurred and gone undetected.
Aside from the main findings, this study also wanted to determine the behavioural
differences between injected and non-injected controls. Although most behavioural
measures showed no difference between the NaCl-PBS and No Tx control groups, the
measure of percent habituation to the startle response was an exception. The No Tx group
showed greater habituation to the startle response than the injected treatment groups in
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adulthood. This suggests that on certain behavioural measures, it is important to have a
control group that receives no injection stress. This is corroborated by previous research
that suggests that intraperitoneally injected saline mice show greater anxiety than shaminjected and lightly handled animals on the elevated plus maze (Lapin, 1995). Therefore,
it may be wise to include a no treatment control group for measures sensitive to anxiety.

2.4.4

Conclusions

Although animals share many physiological and behavioural characteristics with humans,
it is unlikely that they will perfectly mirror human pathological diseases. However, these
models are useful in examining physiological changes and elucidating therapeutic
mechanisms that cannot be assessed in humans (Nestler & Hyman, 2010). Modeling of
these human neuropsychiatric disorders such as ASD is extremely challenging as
symptoms of these disorders are complex and may not map perfectly onto human
symptoms. Crawley (2004) has provided a list of symptoms and hypothesized analogous
tests to model ASD behaviour. The present study hoped to establish face validity and
construct validity of the immune and PPA model of ASD by assessing anxiety
behaviours and responses to sensory stimuli. Future studies should aim to evaluate this
model’s effect on social interaction and restricted interests through social approach and
novel object exploration tasks.
In summary, the present study assessed the effects of repeated adolescent LPS and
adolescent PPA, and adulthood PPA on anxiety and exploratory behaviour, ASR and
%PPI. The results of this study suggest that repeated early adolescent exposure to
immune stimuli can induce long-term effects as assessed through the increase in startle
response long after sickness response has dissipated. LPS also produces organizational
changes that alter behaviour in rats by decreasing activity and producing depressive-like
symptoms. PPA acutely decreases activity and exploration behaviours, while decreasing
ASR and %PPI. The complex interactions of these two compounds can mirror the hyper
and hypo-sensitivity to sensory stimuli found in individuals with ASD. The present study
will guide further research in understanding how environmental insults can contribute to
changes in neurophysiology and the gut microbiome to result in the development of
neuropsychological disorders including ASD.
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Chapter 3

3

Exposure to predator odour in early adolescence alters the
behavioural reactions of male rats to propionic acid
treatments later in adolescence and adulthood on measures of
anxiety and sensory sensitivity

3.1

Introduction

Autism spectrum disorders (ASD) are a group of developmental disorders including
Autistic Disorder, Asperger Syndrome, and Pervasive Developmental Disorder-Not
Otherwise Specified, characterized by deficits in social communication, repetitive and
restricted interests, and altered sensitivity to sensory stimuli (APA, 2013). There is a 4:1
male to female ratio in this disorder’s prevalence (CDC, 2012), which underlies the
importance of studying males with the disorder. Although ASD is so widespread, the
causes for ASD are widely unknown but has been suggested to have both genetic and
environmental origins.
A meta-analysis on ASD has estimated between 64 – 91% heritability of this disorder,
which suggests a large genetic component (Tick et al., 2016). However, genes cannot
account fully for the prevalence of ASD. Environmental stressors during early life
increases the risk for clinical disorders including anxiety and depression (Lupien et al.,
2009). Prior research has suggested that early life stressors may decrease an individual’s
threshold towards these psychopathologies, especially during prenatal and postnatal
developmental periods. However, limited research has studied the importance of the
adolescent period on developmental disorders such as ASD. This period has been
hypothesized to be a “sensitive period” for stress response programming and social
development (Wright, Muir & Perrot, 2012; Spear, 2000). Stressors during this period
activate the hypothalamic-pituitary-adrenal (HPA) axis which is predicted to have long
term consequences. As such, it is important to consider whether early adolescent social
stressors, such as that provided by cat odours can predict later behavioural abnormalities.
Predator odours are ethologically relevant and aversive stimuli for rodents (McGregor et
al., 2002). When rats are exposed to cat odours, they tend to produce anxiogenic and
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defensive behaviours, and suppress non-defensive behaviours (Blanchard et al., 1998;
McGregor et al., 2002; Papes, Logan & Stowers, 2010). They also show innate aversion
to the predator odour source by spending less time investigating it in comparison to their
unworn cat collar controls (Wright, Muir & Perrot, 2012).
In addition to the acute anxiogenic effects induced by predator odours, they can also
induce sustained stress across the lifespan. Cat odour exposure during adolescence
elevates corticosterone levels and decreases activity in male and female adult rats in
comparison to their controls (Wright, Muir & Perrot, 2012). Adolescent female rats
repeatedly exposed to cat odour displays an elevated anxiety-like response in adulthood
on an open field (Wright, Muir & Perrot, 2012). This long-term outcome supports the
significance of the adolescent period in stress response programming.
Short-term and long-term stress exposures can alter the gut microbiome by altering its
bacterial profile (Galley et al., 2014). Changes to the gut microbiome have been
suggested to impact neurodevelopmental and psychological disorders. Changes to the gut
microbiome are important environmental risk factors in the development of ASD because
of the intricate and pervasive communication between the gut and the brain. This
feedback system affects immune activation, emotional and cognitive processes, as well as
gut signaling (as reviewed by Foster, Rinaman & Cryan, 2017). Interestingly, a subset of
children with ASD have elevated levels of Clostridium bacteria in their feces (Finegold et
al., 2002). The fermentation products of these bacteria and other ASD-associated bacteria
include propionic acid (PPA) and other short-chain fatty acids (SCFAs). At endogenous
levels, SCFAs are important for energy metabolism (den Besten et al, 2013), however, at
abnormally high levels, the effects can be detrimental.
When administered intracerebroventricularly, acute PPA has been shown to induce
increased locomotor activity (MacFabe et al., 2008; Thomas et al., 2010), abnormal
motor movements, stereotypic behaviour (Thomas et al., 2010), and impaired social
interaction in rodents (MacFabe et al., 2011), similar to that found in the behaviour of
children with ASD (as reviewed by MacFabe, 2012). However, peripheral administration
of PPA has also been suggested to induce abnormal behaviours that may stem from its

53

central effects. Intraperitoneal (i.p.) injection of PPA allows for the systemic
administration of this drug. This model has been used as a less invasive route of
administration of PPA than the intracerebroventricular model. Using the i.p. injection
model, Ossenkopp et al. (2012) found that PPA induced aversive internal cues as
measured through conditioned place avoidance and conditioned taste avoidance.
Repeated PPA i.p. has also been shown to reduce social interaction in juvenile male rats
(Shams et al., submitted). In addition, PPA i.p. decreases prepulse inhibition (PPI) which
is a measure of a decreased ability to filter out auditory stimuli (see Chapter 2).
Taking together the impact of early stressors on neurodevelopmental changes, the present
study hoped to address the following questions. First, the present study determined the
effects of repeated cat odour exposure in early adolescence on male rats on the measures
of anxiety, prepulse inhibition (PPI), and acoustic startle response (ASR) in later
adolescence. It then compared these behaviours with adulthood. This study then
examined the effects of repeated PPA administration in adolescence and adulthood.
Finally, the present study examined the interaction effect of prior adolescent predator
odour exposure followed by later PPA exposure in late adolescence and adulthood. It was
hypothesized that predator odour would induce anxiety-like behaviours during the
exposure, that persists into late adolescence and adulthood. It was further hypothesized
that PPA would produce altered cognitive functioning as assessed by PPI. These effects
of PPA were hypothesized to be augmented by prior exposure to the predator odour.

3.2
3.2.1

Materials & Methods
Subjects

Thirty-two male Long Evans rats were obtained at 51 - 75 g from Charles River, Quebec,
Canada. This weight class corresponds to postnatal day (P) 22. All animals were pairhoused with another rat of the same treatment group in standard polypropylene cages (45
x 22 x 20 cm). They were maintained in a temperature-controlled room at 20 ± 1°C on a
12:12 light-dark cycle (lights on at 0700 to 1900 h). All rats were given ad libitum access
to food (RHM Prolab 3000 rat chow) and tap water. Rats were identified using a numeric
system marked using a permanent marker on their tails. When the tail markings faded, the

54

rats were re-marked. All experimental procedures complied with the Canadian Council
for Animal Care guidelines and the Institutional Animal Care Committee.

3.2.2

Predator Odour Exposure

Animals were exposed to cat odours from collars that were worn by male and female cats
for 2 weeks. Pieces of the collar that were in contact with the cat’s neck were cut into 4
cm lengths and stored in an air-tight plastic bag at -10°C. When the collars were ready for
use, they were handled with latex gloves and warmed to room temperature in a plastic
bag placed in a warm bath. The control cat collars were the same length cat collars that
were never worn by a cat. The piece of collar, whether worn or unworn, was taped to the
VersaMax Animal Activity Monitors (42 x 42 x 30 cm; Accuscan Model RXYZCM-16,
Columbus, OH) by 3 cm of black electric tape at 13 cm from the bottom of the apparatus
and centered on one of the walls of the activity field (see Appendix B.1). Each monitor
was made of clear Plexiglas enclosed by a Plexiglas lid with air-holes. The activity
monitors were equipped with 16 infrared sensors located 7 cm above the floor located
every 2.54 cm along the perimeter on opposing sides of the apparatus. Another 16
infrared sensors were located 18 cm above the floor to detect vertical activity. The cat
collars were placed between the two sets of horizontal infrared sensors to ensure that the
beams were not interfered with by the cat collar itself. Since eight activity chambers were
available to be used simultaneously per session, to minimize odour contamination, each
of these sessions comprised of rats either only in the worn cat collar condition or only the
unworn cat collar condition. Data were collected and analyzed by a VersaMax Analyzer
(Accuscan Model CDA-8, Columbus, OH) and sent to a computer where it was recorded.
The cat odour exposure field was divided into the opposite perimeter zone and the cat
odour exposure area, as seen in Figure 3.1 in the light grey colour. The opposite
perimeter zone was the furthest area away from the cat collar stimulus, while the
exposure area contains the cat collar stimulus. The location of the cat collar stimulus was
represented in black. Rat activity was not analyzed in the undefined areas of the field.
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A)

B)

Figure 3.1 Map of the cat odour exposure field: A) opposite perimeter and B) cat
odour exposure area. Light grey represents the zone analyzed. Black represents the
location of the worn or unworn cat collar stimulus.
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The VersaMax Analyzer collected the total time spent in each of the defined areas and
the number of vertical movements produced in the cat odour exposure area (Table 3.1).
The number of vertical movements were corrected for the rat’s total time spent in the cat
odour exposure area, such that corrected number of vertical movements was calculated as
number of vertical movements per second spent in the cat odour exposure area.
Table 3.1 Behavioural measures recorded in the cat odour exposure field
Behavioural Measures
Duration
Vertical Movement
Numbers

3.2.3

Definition
Time spent in the area.
Number of times animal rears up and goes below the vertical
sensor for at least 1 second before the next rear up.

Drugs

Sodium propionate (P1880, Sigma-Aldrich, St. Louis, MO, USA) at a dose of 500 mg/kg
was dissolved in 0.1 M phosphate buffered saline (PBS) and buffered to pH off 7.5 by
HCl. Sodium propionate and PBS were administered in late adolescence on P40 and P43,
and in adulthood on P74 and P77. A vehicle control using an equivalent volume to body
weight ratio of 0.1 M PBS was injected on the same days for the PBS treatment rats. All
drug treatments were administered intraperitoneally (i.p.) at 2.0 ml/kg body weight. The
dose of 500 mg/kg of sodium propionate i.p. was chosen because it produces reduced
locomotion on the conditioned place avoidance task (Ossenkopp et al., 2012), reduced
social interaction (Shams et al., submitted), and decreased %PPI (see Chapter 2).

3.2.4

Light-Dark Apparatus & Behavioural Measures

Behavioural variables in the light-dark apparatus were collected using eight automated
VersaMax Animal Activity Monitors (Accuscan Model RXYZCM-16, Columbus, OH),
that were the same used in the predator odour exposure. This apparatus was divided into
an illuminated light chamber or dark chamber by a black opaque Plexiglas box insert (40
x 20 x 23 cm). The addition of this insert modifies the context to reduce contextual cues
from the predator odour exposure. The dark chamber had small holes located on the sides
to permit the infrared beams to pass through in order to detect movement. The rats were
permitted to freely pass between the chambers by a hole in the partition between the light
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and dark chambers at floor level. Data were collected and analyzed by a VersaMax
Analyzer (Accuscan Model CDA-8, Columbus, OH) and sent to a computer where it was
recorded and retrieved. Procedures were adapted from Banasikowski et al. (2015).
The VersaMax Analyzer collected two types of behavioural variables: chamber-choice
variables and activity variables (Table 3.2). The chamber choice variables included the
duration spent in the light chamber, number of transitions into the light chamber, and the
number of nosepokes. Nosepokes were observed as investigative stretch-attend postures
extending into the light chamber. These variables provide measures for anxiety-like
behaviours including avoidance of the light chamber and risk-assessment (nosepokes and
transitions between the chambers; Banasikowski et al., 2015).
The second type of behavioural variables recorded by the VersaMax Analyzer were the
activity variables. These included the total cumulative distance travelled, the number of
times the rat rears up, and time spent in vertical position, vertical. All of the activity
variables were recorded in the light and dark chambers, and were corrected for the total
time spent in these respective chambers. For example, corrected total distance in the light
chamber was calculated for the total distance in the light chamber per second spent in this
chamber.
Table 3.2 Behavioural measures recorded on the light-dark anxiety task
Behavioural Measures
Chamber Choice Variables
Light Duration
Light Transitions
Nosepokes
Activity Variables
Total Distance
Vertical Movement
Number
Vertical Time

Definition
Time spent in the light chamber.
Number of transitions from the dark to the light chamber.
Number of investigative postures extending into the light
chamber.
Cumulative horizontal distance travelled.
Number of times animal rears up and goes below the vertical
sensor for at least 1 second before the next rear up.
Time spent in rearing position. This measure does not consider
the time when animal goes below the vertical sensor.
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3.2.5

Acoustic Startle Response & Prepulse Inhibition

Acoustic startle response (ASR) and pre-pulse inhibition (PPI) were conducted on three
startle devices (SRLAB, San Diego Instruments, San Diego, CA). Each apparatus
consisted of a cylindrical, clear acrylic rat enclosure (8.89 cm inside diameter and 20.32
cm length) mounted on an acrylic platform. A piezoelectric accelerometer that lies
underneath the platform detects the force of the rat’s movement in response to the startle
stimulus. This apparatus was placed inside a ventilated sound attenuated box containing
fluorescent lighting and an audio speaker 11 cm from the top back of the box. Data were
recorded and stored by a computer attached to the accelerometer. Procedures were
adapted from Lockey, Kavaliers, and Ossenkopp (2008).
The startle responses were measured as the magnitude of the peak voltage detected by the
startle device during a 100 ms detection period after the onset of the startle stimulus. The
average peak response of each trial type (Startle, 76 dB PPI, 82 dB PPI) was computed.
Percent PPI was calculated as a percent difference from the startle-only startle response
for the 76 dB and 82 dB pre-pulse level for each individual rat. This was calculated using
the following formula:
% 𝑃𝑃𝐼 = 100 ×

3.2.6

𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑜𝑛𝑙𝑦 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒 − 𝑃𝑃𝐼 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒
𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑜𝑛𝑙𝑦 𝑠𝑡𝑎𝑟𝑡𝑙𝑒 𝑚𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒

% Body Weight Change

Body weight change of rats tends to decrease in response to stressors compared to
controls (Stankiewicz et al, 2014; Genné-Bacon, Trinko & DiLeone, 2016). Therefore,
body weight change was used as an indicator of stress in the rats exposed to predator
odours. Body weight change was calculated using the following formula:
% 𝐵𝑜𝑑𝑦 𝑊𝑒𝑖𝑔ℎ𝑡 𝐶ℎ𝑎𝑛𝑔𝑒
= 100 ×

24ℎ 𝑝𝑜𝑠𝑡 𝑡𝑒𝑠𝑡 𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 − 𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑑𝑎𝑦 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
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3.2.7

Experimental Procedure

On the arrival of the rats on P22, they were pair-housed without manipulation for three
days to habituate them to the facility. The animals were handled on their fourth and fifth
day, and weighed and handled on their sixth day. On P27, the rats were assigned to four
weight-matched manipulation groups: 1. CAT ODOUR-PPA, 2. CAT ODOUR-PBS, 3.
NO CAT ODOUR-PPA, and 4. NO CAT ODOUR-PBS. The experimental procedure is
outlined in Figure 3.2.

3.2.7.1

Phase 1: Adolescence

In early adolescence, the rats were exposed to either a cat odour via a worn or no cat
odour via an unworn cat collar stimulus for 30 minutes on days P28, P30, P32, and P34.
Between each exposure session, the apparatus was cleaned with detergent and water,
followed by baking soda in water to remove odours, and dried with paper towel to
remove remaining stains. The rats were weighed the day of, and the day after, each
exposure day to assess body weight change.
Six days after cat odour exposure, the rats were weighed and injected with PPA i.p. or its
vehicle, PBS, in late adolescence on P40. After 15 minutes of wait time, rats were placed
in the light-dark apparatus for 15 minutes. The same cleaning procedure was conducted
as for the predator odour exposure days.
On P43, the rats were again weighed and injected with PPA or PBS i.p. After 10 minutes,
these rats were placed into the acoustic startle apparatus. A 5-minute background noise of
70 dB was played to acclimate the rats to the apparatus, after which they performed the
startle task. The testing phase lasted for 11 minutes, consisting of 45 trials starting with
10 startle-only trials at 120 dB presented for 40 ms. The subsequent 30 trials were
presented in a pseudo-randomized order: 10 startle-only (120 dB for 40 ms) and 20 PPI
trials (ten 76 dB and ten 82 dB non-startling pulses presented for 20 ms and a 120 ms
wait until the 120 dB startle pulse). The session ended with 5 startle-only trials (120 dB
for 40 ms). The startle response was recorded by a computer for 100 ms following the
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Figure 3.2 Experimental timeline.
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onset of the startle stimulus. All trials were separated by an inter-trial interval (ITI) of 823 seconds in length (average ITI = 15 seconds). The startle apparatus force detection
hardware was calibrated at least once every four testing sessions to ensure consistent
recording of startle reactivity. Between each testing session, the animal enclosure was
cleaned with detergent and water, and dried with paper towel to remove remaining stains.

3.2.7.2

Phase 2: Adulthood

The same procedure used in late adolescence on P40 and P43 were conducted in
adulthood on P74 and P77, respectively, whereby the rats received PPA or PBS i.p. on
both P74 and P77 followed by light-dark testing and startle testing.

3.2.8

Statistical Analyses

All statistical analyses were completed using IBM SPSS Statistics 25. Missing values
were replaced by the average value obtained within their respective treatment groups.
Repeated measures analyses of variances (ANOVA) were conducted to compare the
treatment effects across the four cat odour exposure days. Greenhouse-Geisser
corrections were used for repeated measures analyses that violates Mauchly’s Test for
Sphericity. Additionally, the behavioural measures obtained from the light-dark and
acoustic startle response tasks were analyzed using repeated measures ANOVAs to
compare behaviour across adolescence and adulthood. The between-subject factors were
the treatment groups, while the within-subject factors were the adolescent and adult timepoints. The significance criteria was set to α = 0.05 for all hypotheses tested.

3.3
3.3.1

Results
% Body Weight Change

There were no significant differences between treatments on % body weight change 24
hours following each cat odour exposure day (see Appendix B.2).
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3.3.2

Cat Odour Exposure

3.3.2.1

Cat Odour Exposure: Opposite Perimeter

Rats that were exposed to the cat odour (worn cat collar stimulus) spent a greater amount
of time in the opposite perimeter than rats exposed to no cat odour (unworn cat collar
stimulus), F(1, 30) = 11.646, p = .002 (Figure 3.3). This was used as a measure of
thigmotaxis, an anxiety-like behaviour exhibited by rodents in which they spend greater
amounts of time in the outside perimeter of an open field.

3.3.2.2

Cat Odour Exposure: Exposure Area

The cat odour exposure area was the immediate and surrounding area of the cat collar
stimulus. Since the cat collar was placed between the lower infrared sensors and the
upper infrared sensors, vertical movements in this area would indicate exploration and
sniffing of the cat collars. The rats exposed to the cat odour spent less time in the cat
exposure area in comparison to the control rats, F(1, 30) = 7.163, p = .012 (Figure 3.4).
In a separate analysis of each exposure day, it was found that the rats exposed to cat
odour via worn cat collar stimulus showed no significant difference in the duration spent
in the cat exposure area in comparison to their controls on P28. However, this diverged in
the later exposure days to drive the effect shown in Figure 3.4Figure 3.4.
On the measure of corrected vertical time there was an age by treatment interaction
effect, F(3, 90) = 7.004, p < .001, where on P34, the cat odour exposed rats exhibited
more time spent in vertical position than their controls (p = .004; Figure 3.5). There was
also a significant main effect of postnatal day, F(3, 90) = 4.437, p = .006, such that at
subsequent cat odour exposure days, the rats spent more time in vertical position than on
P28 (ps < .005). This effect was driven by the increase in vertical time by the cat odour
exposed rats.
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Figure 3.3 Duration spent in the opposite perimeter of the cat odour exposure area
on P28, 30, 32 and 34. Rats were exposed to a cat odour via a worn cat collar (n = 16) or
no cat odour via an unworn (n = 16) cat collar stimulus. The cat odour exposed rats spent
more time in the opposite perimeter than the unworn cat collar exposed rats. **p < .01.
Data is represented as mean ± SEM.
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Figure 3.4 Duration spent in the cat odour exposure area on P28, 30, 32, and 34.
Rats were exposed to a cat odour via a worn cat collar (n = 16) or no cat odour via an
unworn (n = 16) cat collar stimulus. The cat odour exposed rats spent less time in the cat
odour exposure area than the unworn cat collar exposed rats. *p < .05. Data is represented
as mean ± SEM.
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Figure 3.5 Corrected vertical time in the cat odour exposure area on P28, 30, 32,
and 34. Rats were exposed to a cat odour via a worn cat collar (n = 16) or no cat odour
via an unworn (n = 16) cat collar stimulus. Corrections were made by dividing the
duration spent in the cat odour exposure area. The cat odour exposed rats spent greater
time in vertical position on P34 than their controls. There is a postnatal day effect, such
that repeated cat odour exposure results in increased time spent in vertical position
compared to P28, driven by the cat odour exposed rats. *p < .05, **p < .01. Data is
represented as mean ± SEM.
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3.3.3
3.3.3.1

Light-Dark: Anxiety & Activity
Chamber-Choice Variables

Following PPA or PBS treatment, the rats were tested on the light-dark apparatus where
their anxiety-like behaviours and activity levels were measured. Anxiety and risk
assessment behaviours were addressed through chamber-choice variables. There was no
significant difference in the duration spent in the light chamber across treatment groups.
However, there was a trend for the main effect of cat odour when adolescent and
adulthood were combined to show a decreased amount of time spent in the light chamber
than the no cat odour exposed rats, F(1, 28) = 3.082, p = .090.
On the risk assessment measure using nosepokes into the light chamber, a main effect of
cat odour when combining adolescence and adulthood was observed, such that prior cat
odour exposure resulted in a decreased number of nosepokes into the light chamber
compared to control odours, F(1, 28) = 4.350, p = .046 (Figure 3.6).
On the number of transitions into the light chamber, there was a main effect of observed
by a decreased number of transitions into the light chamber compared to rats treated with
PBS, F(1, 28) = 22.774, p < .001 (Figure 3.7).

3.3.3.2

Activity Variables: Corrected Horizontal Locomotion

There were no treatment effects on corrected total distance travelled in the light chamber.
The dark chamber gave rise to greater observable differences in activity. A main effect of
PPA when combining adolescence and adulthood was found, such that PPA-treated rats
showed decreased corrected total distance travelled than their PBS controls, F(1, 28) =
21.521, p < .001 (Figure 3.8).

3.3.3.3

Activity Variables: Corrected Vertical Locomotion

In the light chamber, on the measure of corrected vertical time, there was a main effect of
cat odour when adolescence and adulthood were combined, observed by cat odour
exposed rats showing elevated time in vertical position in the light chamber compared to
their controls, F(1, 28) = 9.621, p = .004 (Figure 3.8A). A main effect of PPA was also
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Figure 3.6 Nosepokes into the light chamber of the light-dark apparatus on P40 and
P74. Rats were exposed to a cat odour via a worn or no cat odour via an unworn cat
collar stimulus on P28, P30, P32, and P34 and injected i.p. with PPA or PBS on P40,
P43, and P74 (n = 8/group). A main effect of cat odour exposure when combining
adolescent and adulthood was observed as seen in the graph on the right, such that the cat
odour exposed rats produced fewer nosepokes into the light chamber than the unworn cat
collar exposed rats. *p < .05. Data is represented as mean ± SEM.
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Figure 3.7 Number of transitions into the light chamber of the light-dark apparatus
on P40 and P74. Rats were exposed to a cat odour via a worn or no cat odour via an
unworn cat collar stimulus on P28, P30, P32, and P34 and injected i.p. with PPA or PBS
on P40, P43, and P74 (n = 8/group). A main effect of PPA when combining adolescent
and adulthood was observed as seen in the graph on the right, such that the PPA-treated
rats produced fewer transitions into the light chamber than PBS controls. ***p < .001.
Data is represented as mean ± SEM.
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Figure 3.8 Corrected total distance travelled in the dark chamber of the light-dark
apparatus on P40 and P74. Rats were exposed to a cat odour via a worn or no cat odour
via an unworn cat collar stimulus on P28, P30, P32, and P34 and injected i.p. with PPA
or PBS on P40, P43, and P74 (n = 8/group). Corrections were made by dividing the
duration spent in the dark chamber. A main effect of PPA when combining adolescence
and adulthood was found as seen in the graph on the right, such that PPA-treated rats
produced less corrected total distance travelled than their PBS controls. ***p < .001. Data
is represented as mean ± SEM.
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observed for corrected vertical time in the light chamber, whereby PPA-treated rats
showed decreased corrected vertical time than their PBS controls, F(1, 28) = 4.342, p =
.046 (Figure 3.9A). Additionally in adulthood, the rats administered PPA showed a
decreased corrected vertical time in comparison to the controls (p = .002; Figure
3.9Figure 3.9B).
As in the light chamber, the same main effect of PPA administration was seen in the dark
chamber, where PPA decreases the corrected vertical time in comparison to PBS controls
when adolescence and adulthood were combined, F(1, 28) = 36.970, p < .001 (Figure
3.10A). This effect was observed because both PPA in adolescence and adulthood spent
less time in vertical exploration than their PBS controls in adolescence and adulthood,
respectively (Figure 3.10B).
Cat odour exposure and PPA treatment interaction effects were found for dark corrected
vertical movement numbers and dark corrected vertical time. Cat odour and PBS treated
rats showed greater dark vertical time in comparison to the no cat odour and PBS group,
F(1, 28) = 8.217, p = .008, suggesting that cat odour increased vertical time. Given that
cat odour increases vertical time and that PPA reduces vertical time, their interaction
effect on vertical activity was determined to be antagonistic. Additionally, the rats treated
with cat odour and PPA showed fewer dark corrected vertical movement numbers than
those treated with cat odour and PBS, F(1, 28) = 4.639, p = .040 (Figure 3.11). These
results together suggests that cat odour potentiates PPA’s reduction of vertical
movements, although cat odour by itself increases vertical time.

3.3.4

Acoustic Startle Response (ASR) & Percent Prepulse
Inhibition (%PPI)

The average ASR for a 120 dB startle pulse also produced no significant differences
between the treatment groups. On the measure of sensorimotor gating using a 76 dB
prepulse, a main effect of PPA was observed such that rats treated with PPA showed a
depressed %PPI compared to the PBS controls when adolescence and adulthood were
combined, F(1, 28) = 5.440, p = .027 (Figure 3.12). Using an 82 dB prepulse, the rats
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administered PPA showed a trending decrease in %PPI compared to the PBS controls,
F(1, 28) = 3.863, p = .059.

A)

B)

Figure 3.9 Corrected vertical time in the light chamber of the light-dark apparatus
on P40 and P74. Rats were exposed to a cat odour via a worn or no cat odour via an
unworn cat collar stimulus on P28, P30, P32, and P34 and injected i.p. with PPA or PBS
on P40, P43, and P74 (n = 8/group). Corrections were made by dividing the duration
spent in the light chamber. A) A main effect of cat odour was found as seen in the graph
on the top right, such that cat odour exposed rats spent more time in vertical exploration
than their controls. A main effect of PPA was found as seen in the graph on the bottom
right, whereby PPA-treated rats produced less corrected vertical time than their PBS
controls. B) In adulthood, PBS controls showed greater vertical time than in adolescence,
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and when compared to PPA-treated adults. *p < .05, **p < .01. Data is represented as
mean ± SEM.
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A)

B)

Figure 3.10 Corrected vertical time in the dark chamber of the light-dark apparatus
on P40 and P74. Rats were exposed to a cat odour via a worn or no cat odour via an
unworn cat collar stimulus on P28, P30, P32, and P34 and injected i.p. with PPA or PBS
on P40, P43, and P74 (n = 8/group). Corrections were made by dividing the duration
spent in the dark chamber. A) A main effect of PPA when combining adolescence and
adulthood was found as seen in the graph on the right, such that PPA-treated rats
produced less corrected vertical time than their PBS controls in the dark chamber. B)
This effect was observed because both PPA in adolescence and adulthood spent less time
in vertical exploration than their PBS controls in adolescence and adulthood,
respectively. *p < .05, **p < .01, ***p < .001. Data is represented as mean ± SEM.
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Figure 3.11 Corrected vertical movement numbers in the dark chamber of the lightdark apparatus on P40 and P74. Rats were exposed to a cat odour via a worn or no cat
odour via an unworn cat collar stimulus on P28, P30, P32, and P34 and injected i.p. with
PPA or PBS on P40, P43, and P74 (n = 8/group). Corrections were made by dividing the
duration spent in the dark chamber. There is cat odour by PPA treatment interaction
effect, whereby cat odour exposed rats given PPA showed a decreased number of vertical
movements in the dark chamber than the cat odour and PBS exposed rats. *p < .05. Data
is represented as mean ± SEM
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Figure 3.12 % Prepulse inhibition for a 76 dB prepulse with a baseline of 70 dB
followed by a 120 dB startle pulse on P43 and P77. Rats were exposed to a cat odour
via a worn or no cat odour via an unworn cat collar stimulus on P28, P30, P32, and P34
and injected i.p. with PPA or PBS on P40, P43, P74, and P77 (n = 8/group). A main
effect of PPA when combining adolescence and adulthood was found as seen in the graph
on the right, such that PPA-treated rats showed a decreased %PPI to a 76 dB prepulse
than their PBS controls. *p < .05. Data is represented as mean ± SEM.
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3.3.5

Summary of Results

This study showed that early adolescent repeated cat odour exposure was aversive to the
rats and induced anxiety-like behaviours during the exposure period. When the
adolescent and adulthood periods were combined, a main effect of early adolescent
repeated cat odour exposure induced elevated anxiety-like behaviours. A main effect of
PPA was observed, such that PPA decreased activity levels as assessed through
horizontal and vertical locomotor variables when adolescent and adulthood were
combined. PPA administered rats also showed a decreased % PPI for a 76 dB prepulse
when adolescent and adulthood were combined. Finally, prior repeated cat odour
exposure induced an antagonistic effect of PPA on escape behaviours, whereby prior cat
odour exposure potentiated PPA’s reduction of vertical movement numbers.

3.4
3.4.1

Discussion
Early adolescent repeated cat odour exposure was aversive
and anxiogenic

Early adolescent repeated cat odour exposure produced aversive and anxiogenic
responses in the rats. The rats were able to detect and display avoidance behaviour in
response to the cat odour exposure, which indicates that the cat odour exposure was
stressful. The anxiety behaviours presented by the rat did not habituate throughout the cat
odour exposures. During the exposure days, they spent more time in the opposite
perimeter of the cat odour exposure area with minimal horizontal movement, and a
decreased number of vertical movements in comparison to their controls. The rats were
motivated to avoid the potentially threatening stimulus as much as possible by spending
time in the regions furthest away from the cat odour stimulus. This is consistent with
previous research that showed that when rats are given a hide box in which they can hide
from the predator odour, they tend to spend most of their time in this hide box and
produce a “head out” stance in which they face the predator odour stimulus without
turning their heads (McGregor et al., 2002; Dielenberg, Carrive & McGregor, 2001). By
directly facing the odour stimulus, with their heads protruding out of the entrance of the
hide box, these rats are engaging in risk assessment behaviour which is an adaptive
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response to a potentially threatening stimulus. The deficit in horizontal movements
observed in the rats repeatedly exposed to predator odour is not surprising as rats tend to
elicit anxiety-like behavioural responses such as freezing and immobility in response to
stressors (McGregor et al., 2002; Dielenberg, Carrive & McGregor, 2001).
After assessing the locomotor activity within the cat odour exposure area, it is clear that
the rats exposed to the predator odour chose to spend much less time in the area than their
controls. This may be explained either by the increased time spent at the cat collar
stimulus by controls rats in investigating a novel stimulus and/or the decreased time spent
at the worn cat collar stimulus because of its aversiveness. In future studies, this
limitation can be resolved by having a control condition in the open field without a cat
collar stimulus. This result, in addition to the previous findings of the increased
anxiogenic behaviour in which the cat odour exposed rats spent more time in the opposite
perimeter than their controls, suggests the cat odour stimulus has anxiogenic and aversive
properties. When analyzing each exposure day separately for the time spent in the cat
odour exposure area, on the first day of exposure (P28), the rats showed no significant
difference between the cat odour and no cat odour groups. This could suggest that the rats
were stressed by the novel open field. They were likely more focused on the stress
associated with the open field. However, on P30, P32, and P34, the aversion to the
predator odour stimulus and/or the attractiveness to the unworn cat collar was evident.
In the present study, rats’ avoidance behaviour, demonstrated by the duration spent in the
opposite perimeter of the cat odour exposure area and the odour exposure area itself, did
not habituate. However, within the cat odour exposure area, the rats explored the cat
collar stimulus to a greater extent on the fourth exposure day (P34) than on the first
exposure day (P28) as shown by the vertical measures of activity corrected for the time
spent in this region. This is not surprising as previous studies show increased stimulus
investigation after 5 repeated cat odour exposure sessions (Wright, Muir & Perrot, 2012),
which suggests an increasing interest in the stimulus. Taken together, these results
suggest that certain behaviours occurred independent of habituation. Perhaps the cat
odour stimulus became more interesting once the animals learned that the stimulus itself
is not harmful in nature. The literature on habituation to predator odour is inconclusive.
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Some researchers have shown that avoidance behaviours do not habituate (File et al.,
1993; Masini et al., 2006; Blanchard et al., 1998), while others have found that certain
behaviours habituated over time to the stimulus (Dielenberg & McGregor, 1999;
McGregor et al., 2002). Since predatory fear is an innate and salient response in prey
animals, it not surprising that predator cues can elicit behavioural and endocrine
responses independent of habituation. Plasma corticosterone levels have been shown to
increase across chronic exposure days, which suggests that habituation did not occur
(Blanchard et al., 1998). Contrary to this, other researchers including Dielenberg and
McGregor (1999) found that hiding behaviour did habituate in response to a worn cat
collar over daily repeated exposures. Further, McGregor et al. (2002) found that the
immobility response decreased over time. The present study continues to show that some
behaviours habituate while others do not.
When the rats were later tested on an anxiety measure, the light-dark apparatus, a main
effect of cat odour exposure produced an anxiogenic response in later adolescence and
adulthood. The cat odour exposed rats showed fewer nosepokes into the light chamber
than their controls, they showed hyperactivity in the light chamber, as well as increased
time in vertical position in the light chamber, indicating an elevated desire to escape.
Given that these light-dark testing sessions occurred six days and forty days following the
cat odour exposure, this study supports prior research indicating that predator stress can
induce long-term anxiogenic effects as assessed through anxiety behavioural assays
(Bazak et al., 2009; Wright, Muir & Perrot, 2012; Avital et al., 2006). This sustained
psychological stress response exhibited by the rodent is adaptive in preventing similar
life-threatening circumstances in the future.
Although anxiogenic effects were observed, it is also important to consider the possible
generalization of the anxiety response from the similar context presented in the predator
odour exposure phase to the light-dark testing phase. Since both occur in the same testing
arena, it is likely that an anxiogenic response observed in the light-dark task could have
been conditioned. Conditioned fear would not be surprising as repeated adolescent cat fur
exposure elicits conditioned fear by reducing distance travelled and increasing time spent
inside of a hide box when rats are tested in early adulthood on P58 (Kendig et al., 2011).
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Another possible mechanism by which predatory stress induces long-term anxiogenic
effects is through its ability to alter the excitatory and inhibitory balance in neural
circuitry. When exposed to a fearful stimulus, excitatory NMDA receptors are activated
as the magnesium ion that blocks the channel is displaced, thereby opening the NMDA
receptor channel (Davis, Rainnie & Cassell, 1994). When NMDA receptors are blocked
by an antagonist, anxiety behaviours and risk assessment following exposure to cat
odours are reduced when assessed one week later (Adamec et al., 1998). This suggests
that NMDA receptors are involved in long-term anxiety-like behaviour produced by cat
odour stress. These processes are thought to be important in establishing fear-related
memories in models of post-traumatic stress disorder and can also explain the long-term
anxiogenic effects observed.
In addition to the excitatory neurotransmission induced by activation of NMDA
receptors, cat odour exposure also increases the release of the inhibitory neurotransmitter,
GABA, and decreases its uptake in the hippocampus and cortex (File, Zangrossi &
Andrews, 1993). GABA is important in regulating PPI of an acoustic startle response
(Yeomans et al., 2010). However, in the present study, no significant treatment effects
were observed on the measure of PPI. This was not surprising as previous literature has
shown that predator exposure decreases PPI 24 hours after exposure, but not after 48
hours or after 9 days (Bakshi et al., 2012). Since the present study assessed PPI 9 days
and 43 days after cat odour exposure, it is likely the PPI deficits produced by predator
odours were not detected.
Although previous studies on early stressors (Avital et al., 2006) and predator stress show
an increased mean startle amplitude (Bazak et al., 2009), the present study found no
effect of the stressor on startle response. Perhaps there are methodological differences,
for instance, testing in Bazak et al. (2009) occurred on P60, while the present study tested
the rats on P43 and P77. The cat odour exposure methodology also differed between the
studies such that Bazak et al. (2009) used an acute cat litter exposure on P28 instead of a
repeated cat collar stimulus exposure across four days as in the present study. Differences
in methodology may lead to differences in results, hence, there is room for further
investigation.
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In addition, prior research has suggested that males respond less to the predator odour
stressor than females, perhaps explaining why ASR and PPI show no significant effects
of cat odour treatment. Adult male rats exposed to cat odour stimuli in an open field
containing a hide box show more risk assessment behaviour and spend more time in the
proximity of the stimulus than their adult female counterparts (Jolles et al., 2015).
Further, female rats repeatedly exposed to a cat odour stimulus in adolescence show
elevated anxiety behaviours compared to male rats in adulthood by spending more time
in a hide box in an open field than their male counterparts (Wright, Muir & Perrot, 2012).
Future research should investigate the sex differences in early adolescent repeated cat
odour exposure on anxiety-like behaviour, startle response, and PPI in adulthood.

3.4.2

PPA administration decreased activity and sensorimotor
gating

PPA administration occurred at four separate time points, twice in adolescence and twice
in adulthood. The first dose produced acute effects, while subsequent PPA exposures
produced repeated effects. PPA administration reduced activity localized to the dark
chamber of the light-dark apparatus, which is considered to be the “safer” chamber of the
light and dark chambers of this apparatus. In the present study, the rats administered PPA
showed a decreased number of transitions into the light chamber, decreased total distance
travelled in the dark chamber, decreased vertical time in the light and dark chambers.
These results support the findings from Chapter 2, which show that PPA reduced activity,
likely due to the aversive internal state produced by PPA causing a reluctance to move.
Although PPA had no effect on startle response, it did decrease % PPI which is a measure
of sensorimotor gating, the ability to filter out redundant auditory information.
Sensorimotor gating is an important measure of cognitive dysfunction as it is a symptom
of many neurological disorders including schizophrenia, and a subset of individuals with
Autism Spectrum Disorder. This sensory filtration of information occurs through a
feedforward inhibitory pathway involving the cochlear nucleus, inferior colliculus,
superior colliculus, and tegmentum which sends information to the reticular formation
(Swerdlow et al., 1992; Sinclair et al., 2017). When changes are made to this neural
circuitry, sensorimotor gating deficits occur.
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Given that peripheral administration of PPA has also been shown to induce conditioned
place avoidance and conditioned taste avoidance (Ossenkopp et al., 2012), while direct
intracerebroventricular administration of PPA has been shown to induce stereotypic
behaviour, hyperactivity, social impairment, restricted preference for objects, and
behavioural rigidity (MacFabe et al., 2011), there is support for the hypothesis that PPA
has central effect. There are a number of manners in which peripheral administration of
PPA can elicit central effects. PPA is able to bind to SCFA G-protein coupled receptors,
primarily FFAR2, which is involved in immune function and is expressed on immune
cells including enteric leukocytes (Nøhr et al., 2013), monocytes and neutrophils (Ang,
Er & Ding, 2015). Centrally, PPA activates microglia of the hippocampus and white
matter (MacFabe et al., 2011) that releases proinflammatory cytokines as evidenced in
autism spectrum disorder (Vargas et al, 2005). Surprisingly, FFAR2 are not expressed on
microglia, which are the resident immune cells of the central nervous system (Sampson et
al., 2016; Erny et al., 2015). Peripheral PPA may enter the brain by passing the gut-blood
barrier and the blood-brain barrier via a monocarboxylate transporter (Pierre & Pellerin,
2005). Peripheral PPA has been shown to peak in the brain at 60 min following its
administration (Brusque et al., 1999).
Once in the brain, PPA may alter neural circuitry by potentiating glutamatergic and
inhibiting GABAergic transmission which may impact the excitatory and inhibitory
balance in neural circuitry (MacFabe, 2012). GABA is an important neurotransmitter for
prepulse inhibition of the acoustic startle response, such that when GABAA receptors are
disrupted by an antagonist, PPI is reduced (Yeomans et al., 2010). As such, inhibiting
GABAergic transmission can result in a decreased PPI as observed with PPA
administration. Further, PPA can also lead to intracellular acidification by uncoupling
gap junctions between neurons and disrupting synaptic transmission in the prefrontal
cortex and sensorimotor cortex (Rörig et al., 1996). Together, these effects of PPA on
neural circuitry can explain the deficits in sensorimotor gating.
In addition to the short-lived effects of PPA on behaviour and neuronal functioning,
PPA’s effects in adulthood seemed to decrease in comparison to adolescence. Although
PPA was administered at four separate time points, the effect of PPA in adulthood
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decreased. This was not expected as previous literature has suggested a double-hit model
of PPA exposure towards increased dysfunction (Foley et al., 2015). Foley et al. (2015)
administered PPA prenatally and postnatally, and found that PPA induced an increased
ASR when tested in adolescence, suggesting elevated behavioural changes produced by
repeated PPA administration. The present study did not show these same results, and
instead found decreased behavioural changes in adulthood when repeatedly exposed to
PPA in both adolescence and adulthood. Perhaps methodological differences can explain
the differences in results, particularly in the timing of PPA administrations. Further,
behavioural changes were diminished in adulthood, which suggests that behavioural
tolerance may have been produced by repeated PPA exposure. Further research is
warranted as this area of research is limited and is necessary to understand the effects of
repeated PPA exposure in adolescence and adulthood.

3.4.3

Prior repeated cat odour exposure potentiates the reduction
of escape behaviour induced by PPA

There was a significant interaction effect of cat odour and PPA treatment, such that rats
exposed to cat odour and PPA showed a decreased number of dark vertical movements
compared to rats exposed to cat odour and PBS, suggesting that PPA reduces dark
vertical movements. There were no significant differences between the cat odour and
PBS and no cat odour and PBS groups such that cat odour by itself did not alter dark
vertical movement numbers. This suggests that the prior cat odour exposure potentiates
PPA’s depression of exploratory and escape behaviours as assessed through vertical
movements produced in the dark chamber.
This antagonistic effect of cat odour exposure on PPA as measured through behaviour
can be explained by both treatments’ effects on excitatory and inhibitory neural circuitry.
Cat odour exposure can activate excitatory NMDA receptors (Adamec et al., 1998) to
produce long-term anxiogenic behavioural effects. It can also increase the release of the
inhibitory neurotransmitter GABA, and decrease GABA’s uptake (File, Zangrossi &
Andrews, 1993). PPA can also alter the excitatory and inhibitory balance by potentiating
glutamatergic excitatory neurotransmission and inhibiting GABAergic inhibitory
transmission (MacFabe, 2012). These two treatments appear to have slightly different
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effects, such that cat odour exposure increases the availability of GABA, while PPA
decreases the availability of GABA, which may explain their antagonistic behavioural
effect on vertical locomotor variables. However, further research is warranted.
Stress is capable of increasing the permeability of critical barriers including the gut blood
barrier (Kelly et al., 2015; Larauche, Kiank & Tache, 2009; Overman et al., 2012) and
the blood brain barrier (Sharma, Cervós-Navarro & Dey, 1991; Esposito et al., 2002).
Barrier dysfunction may allow for macromolecules including SCFAs like PPA to bypass
the barriers to gain access to the central nervous system. Although the present study uses
i.p. injection of PPA, which bypasses the gut-blood barrier, the systemic PPA
administered may enter the brain with greater ease than without cat odour exposure,
which has direct relevance to ASD.
Another important area of research that may explain the interaction effect observed with
cat odour and PPA, is the stress produced by multiple environmental “hits” during
sensitive periods of development. Research on many models of neural dysfunction stem
from the double hit hypothesis or multiple hit hypothesis including research on
schizophrenia (Maynard et al., 2001) and ASD (Picci & Scherf, 2015).

3.4.4

Conclusions

Despite animals sharing many physiological and behavioural characteristics with humans,
it is unlikely that animal models can perfectly mirror human pathological diseases.
Animal models are useful in that they can be used to examine physiological changes and
to elucidate therapeutic mechanisms that cannot be assessed in humans (Nestler &
Hyman, 2010). Neurodevelopmental disorders such as ASD are complex in its etiology
and hence, also have complex symptomatology. The behaviours observed in individuals
with ASD may not perfectly map onto behaviours observed in animal models. However,
the present study attempted to establish face validity and construct validity of a stress and
PPA model of ASD. It assessed this model by measuring anxiety-like behaviour, acoustic
startle response, and prepulse inhibition, behaviours that are found to be abnormal in
many cases of ASD.
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In summary, early adolescent repeated predator odour exposure was aversive to the male
rats. When tested on an anxiety measure in later adolescence and adulthood, the prior
repeated predator odour exposure produced long-term anxiety-like behaviour, which
further supports previous research that suggests that the adolescent period is a sensitive
period in stress response programming (Wright, Muir & Perrot, 2012). In addition, PPA
administration decreased the rats’ motivation to move, while also decreasing the rats’
ability to filter out redundant auditory information. The predator odour exposure
condition predisposed rats that were later administered PPA to a more enhanced
reduction in escape behaviour as assessed on the light-dark apparatus.
These results together may suggest that stress induced by early adolescent repeated
predator odour exposure may induce imbalances in the excitatory and inhibitory neural
circuitry that is also impacted by PPA administration to induce behavioural changes. This
study also supports the multiple hit hypothesis towards neural dysfunction.
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4

General Discussion

This thesis examined the impact of early adolescent stressors, including immune stress
and predator stress, followed by propionic acid (PPA), on anxiety-like behaviour,
acoustic startle response (ASR), and prepulse inhibition (PPI) in later adolescence and
adulthood. The results of the studies emphasize the importance of adolescent stress on
long-term behavioural outcomes. In chapter 2, when the adolescent rats were repeatedly
exposed to the immune activating agent, lipopolysaccharide (LPS), a delayed increase in
ASR was observed in adulthood. LPS also increased the rats’ anxiety-like behaviour and
escape behaviours. When adolescence and adulthood were combined, administration of
PPA resulted in decreased PPI, which is an indicator of cognitive dysfunction. Together,
LPS and PPA decreased activity variables in an additive fashion as observed on the lightdark apparatus. However, they had opposing effects on ASR such that PPA reduced ASR,
while LPS induced a delayed increase in ASR.
In chapter 3, the impact of PPA closely resembled that observed in chapter 2, such that it
decreased activity and altered PPI. Early adolescent cat odour exposure increased
anxiety-like behaviour in males during the exposure period. When adolescent and
adulthood testing on the light-dark apparatus were combined, elevated anxiety levels
were found for the rats previously exposed to cat odours. Further, prior exposure to cat
odour stress potentiated PPA’s effects such that escape behaviours decreased in the dark
chamber of the light-dark apparatus when administered both cat odour and PPA.
These research findings together indicate a need for further research on the effects of
various environmental and psychological stressors on the adolescent period of
development. Currently, there is a lack of research using adolescent immune activation to
study behavioural changes in adulthood. Many studies assessing the behavioural effects
of LPS tend to administer LPS either prenatally or neonatally to assess their long-term
behavioural effects. Although there are some studies on adolescent LPS administration,
these tend to involve acute doses followed by testing within 24 hours of the immune
insult, during which animals are displaying sickness responses (Doremus-Fitzwater et al.,
2015; Goble et al., 2011). There is a clear lack of research on behavioural studies using
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LPS during this time period. Although a study of LPS administration on P14 pups
showed elevated anxiety-like behaviours in adolescence and adulthood along with spatial
memory deficits (Dinel et al., 2014), this LPS administration occurred before the
adolescent developmental period. The present thesis is the first to date to show that
adolescent repeated LPS exposure results in a delayed increase in startle response in
adulthood. Together, these studies pave the way for further research on adolescent stress
response programming, social development, and cognitive dysfunction in adulthood, and
the reduced resilience to future stressors.
The finding that repeated cat odour exposure in adolescence followed by PPA
administration, decreased escape behaviours to a greater extent than either treatments
themselves, could suggest a link between stress response and the gut-brain axis. These
results support the hypothesis that HPA axis activation leads to increased BBB
permeability (Esposito et al., 2002), thereby influencing PPA’s ability to bypass the BBB.
Another possible mechanism by which cat odour may interact with PPA is through their
actions on altering the excitatory and inhibitory balance. Cat odour exposure has been
shown to increase the release of the inhibitory neurotransmitter, GABA, and decrease its
uptake, such that elevated levels of GABA are found in the synapses within the
hippocampus and cortex (File, Zangrossi & Andrews, 1993). Cat odour exposure also
elevates excitatory processes by elevating glutamate levels that can bind to NMDA
receptors (as reviewed by Davis, Rainnie & Cassell, 1994). PPA on the other hand can
cause excitotoxicity by increasing glutamatergic transmission and decreasing GABAergic
transmission (Brusque et al., 2001).
While the present studies were limited in assessing the behavioural effects of PPA, it is
possible that future studies may use antibiotic-induced gut depletion to assess the effects
of PPA without disruption from other bacterial metabolites. This type of manipulation,
using gut depletion followed by SCFA administration seems to be gaining interest in
literature as endogenous levels of SCFA administration has been shown to reduce
behavioural abnormalities observed in gut depleted animals (Kiraly et al., 2016).
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4.1

Relation to Autism Spectrum Disorders

Since the purpose of this thesis was to model ASD in rats, it is imperative to take the
results of the present study and relate it back to ASD. The ASD phenotype is quite
variable and consists of many different behavioural alterations. The two behaviours that
were assessed were sensory processing alterations and anxiety-like behaviours.
Children with ASD tend to have deficient inhibitory control of sensory information such
that they may be overloaded with sensory information and external stimulation (Sinclair
et al., 2017). Adults and children with ASD tend to show greater startle response, which
indicates an elevated sensitivity to auditory stimuli (Takahashi et al., 2016, Kohl et al.,
2014). Many studies with ASD in adults and children show no changes in sensorimotor
gating as assessed by % prepulse inhibition (PPI), however, the severity of autistic traits
have been correlated with deficits in PPI. In addition, other psychiatric disorders such as
schizophrenia have been characterized by deficits in PPI (Braff et al., 2001). Hence, PPI
is an information measure of cognitive deficits observed in clinical disorders. This thesis
showed that LPS induced an increased startle response in adulthood, while PPA induced
deficits in PPI, suggesting that these rodents experienced cognitive dysfunction.
Anxiety-like behaviour was the other behavioural assay used in this study. Although
anxiety is not a core symptom of ASD, 11 to 84% of individuals with ASD have a
comorbid diagnosis with a form of anxiety disorder (White et al., 2009). Therefore, it is
important to study anxiety-like behaviour, in addition to activity and escape behaviour
that can be measured through the light-dark apparatus. Cat odour and LPS both produced
long-term anxiogenic effects, which are indicative of behavioural abnormalities.

4.2

Conclusions

Overall these studies examined putative risk factors that may result in behaviours that
resemble ASD in humans. It aids in the development of an ASD-like phenotype observed
in rodents, as well as other models of neuropsychopathology. These research findings
will inform future research on the impact of early adolescent stressors and their impact on
behaviour, and the underlying processes that may contribute to dysfunctional behaviours.
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Appendix A.
Additional Figures from Chapter 2

Appendix A.1 % Prepulse Inhibition for an 82 dB prepulse on P43 and P77. Rats
were injected i.p. with LPS, NaCl, or had No Tx on P28, 30, 32, and 34 and PPA, PBS, or
had No Tx on P40, 43, 74, and 77 (n = 12/injected group or n = 8/No Tx group). The
LPS-PPA treated rats showed decreased %PPI for an 82 dB prepulse compared to their
NaCl-PBS controls in adolescence. *p < .05. Data is represented as means ± SEM.
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Appendix B.
Additional Figures from Chapter 3

Appendix B.1 Cat odour exposure chamber. Activity monitors were 42 x 42 x 30 cm,
with the cat collar stimulus placed 13 cm from the bottom of the apparatus centered on
one of the walls of the activity field. Black electric tape was used to tape the 4 cm piece
of cat collar onto the wall.
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Appendix B.2 Mean percent body weight change 24-hours post cat odour exposure.
Rats exposed to cat odour via a worn cat collar or no cat odour via an unworn cat collar
stimulus on P28, 30, 32, and 34 depending on their treatment condition. There were no
significant differences between treatment group. Mean % body weight change decreased
across age. **p < .01. Data is represented as mean ± SEM.
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